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 Acetolactate synthase (ALS) and acetohydroxyacid synthase (AHAS) are two 
thiamin diphosphate (ThDP)-dependent enzymes that catalyze the formation of acetolactate from 
two molecules of pyruvate. In addition to acetolactate, AHAS can catalyze the formation of 
acetohydroxybutyrate from pyruvate and α-ketobutyrate. When formed by AHAS, these 
compounds are important precursors to the essential amino acids valine and isoleucine. 
Conversely, ALS forms acetolactate as a precursor to 2,3-butanediol, a product formed in an 
alternative pathway to mixed acid fermentation. 
While these enzymes catalyze the same reaction, they have been found to be quite different. 
Such differences include: biological function, pH optimum, cofactor requirements, reaction 
kinetics and quaternary structure. Importantly, AHAS has been identified as the target of the 
widely-used sulfonylurea and imidazolinone herbicides, which has led to many structural and 
kinetic studies on AHAS enzymes from plants, bacteria, and fungi. ALS, on the other hand, has 
only been identified in bacteria, and has largely not seen such extensive characterization. Finally, 
although some bacteria contain both enzymes, they have never been studied in detail from the 
same organism.  
Here, the ALS and AHAS enzymes from Klebsiella pneumoniae were studied using steady-
state kinetic analyses, X-ray crystallography, site-directed and site-saturation mutagenesis, and 
cell growth complementation assays to i) compare the kinetic parameters of each enzyme, ii) 
compare the active sites to probe their differences in substrate profile and iii) test the ability of 
ALS to function in place of AHAS in vivo. 
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CHAPTER 1.  INTRODUCTION 
1.1 Thiamin diphosphate 
In the early 1900’s, Neuberg and Karczag (1) made the initial discovery of a thiamin 
diphosphate (ThDP)-dependent enzyme, α-carboxylase, now known as pyruvate decarboxylase 
(PDC), when they observed that fermenting yeast culture was able to transform pyruvate from 
glycolysis into acetaldehyde. With no chemical information to refer to, the mechanism of 
acetaldehyde formation was the subject of some speculation. The earliest of the proposed 
mechanisms stemmed from the observation that primary amines catalyze the decarboxylation of 
α-ketoacids. Later called the Lagenbeck cycle (2), the mechanism proposed that the catalytic center 
of α-carboxylase was a primary amine and reaction would proceed through the formation of a 
Schiff base, i.e., similar to the mechanism now known to be employed by pyridoxal phosphate-
dependent enzymes (3).  
The transformation of pyruvate to acetaldehyde in yeast was later found to be dependent 
on a cofactor called cocarboxylase (4), a compound of previously unknown function first described 
in 1931 by Auhagen (5). In the same study, Lohmann and Schuster (4) identified cocarboxylase as 
the diphosphate ester of thiamin, or vitamin B1. Fortunately, as there had been considerable 
interest in vitamin B1 due to its importance in diseases such as beriberi (6), its chemical structure 
had been published two years prior (7,8). The overall structure of thiamin (Figure 1.1 A) was 
reported to consist of a substituted pyrimidine ring connected to a thiazolium ring through a single 
methylene carbon. The thiazolium ring was found to contain two additional substitutions, a methyl 
group at C4, and an ethyl alcohol group at C5 (7,8). The structure of ThDP (Figure 1.1 B) was 
found to be similar to that of vitamin B1 with the only difference being the replacement of the 
alcohol group with a diphosphate group (4).  
Immediately after the identification of cocarboxylase as ThDP, Melnick and Stern, who 
proposed that the cofactor functioned in an oxidation-reduction cycle, set out to investigate the 
catalytic center of ThDP (9). As the structures of thiamin showed the presence of a primary amine 
making the Lagenbeck cycle possible, they examined the reactivity of the 4’ amino group found 
on the pyrimidine ring by treatment with ketene, a compound that readily acetylates primary 
amines. No evidence of the formation of N-acetylated thiamin was observed, leading to the 
18 
 
conclusion that the amine was not as reactive as other primary amines and, as such, could not be 
the reaction center as previously proposed (9). While this study supported their proposed 
oxidation-reduction cycle, they later published evidence showing that reduced thiamin was 
completely inactive, making catalysis via an oxidation-reduction cycle unlikely (10). 
 
 
Figure 1.1: Chemical structures of A) thiamin, and B) thiamine diphosphate with the 
typical numbering scheme. 
 After Melnick and Stern showed that the catalytic center was not likely to be the 
primary amine, attention shifted to other groups in the cofactor. Not long after, it  was found that 
thiazolium compounds, including thiamin, could catalyze the condensation of two molecules of 
benzaldehyde to form benzoin (3). The overall reaction was similar to the same reaction previously 
reported to be catalyzed by cyanide (11), and suggested the involvement of the thiazolium ring in 
catalysis. 
Armed with this information, Ronald Breslow proposed that the connecting methylene 
carbon was the catalytic center of ThDP. He initially suggested that the first step of the reaction 
was deprotonation of the methylene carbon, forming a reactive carbanion (12). This was later 
disproved when it was revealed that the hydrogen atoms on the methylene carbon did not exchange 
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for deuterium in D2O by 1H NMR (13). Shortly after, using the same technique that disproved his 
original proposal, Breslow identified C2 as the active center of ThDP by showing that the C2 
hydrogen was exchanged for deuterium at a relatively rapid rate (14).  
Deprotonation of C2 results in the formation of the thiazolium ylid (Figure 1.2).  It was 
shown that this zwitterionic species is structurally similar to the cyanide ion, and could act in a 
similar manner in the benzoin condensation (15). These observations led Breslow (16) to propose 
the first widely accepted mechanism involving thiamin as a catalyst for the benzoin condensation 
(Figure 1.3 A). He proposed that the reaction occurs involves five basic steps: i) deprotonation of 
C2 resulting a thiazolium ylid, ii) attack by the ylid on the carbonyl of benzaldehyde, iii) 
deprotonation of the hydroxybenzylthiazolium intermediate to form a resonance stabilized 
carbanion, now known as the Breslow intermediate (Figure 1.3 B), iv) attack of the Breslow 
intermediate on the carbonyl of a second benzaldehyde molecule, and v) release of the benzoin 
product and regeneration of the thiazolium ylid. 
In the years since Breslow’s original proposal, many mechanistic studies have been 
performed on both enzymatic and non-enzymatic systems, and the accepted mechanism of thiamin 
catalysis has remained basically the same; deprotonation of C2 followed by attack on a carbonyl 
of a substrate, usually a α-ketoacid, aldehyde, or α-hydroxyketone (3,17). 
 
 
Figure 1.2: Deprotonation to form the thiazolium ylid. 
Reproduced from Breslow (16). 
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Figure 1.3: A) Reaction intermediates for the benzoin condensation by thiazolium salts, B) 
Breslow intermediate. Reproduced from Breslow (16). 
1.2 Thiamin diphosphate-dependent enzymes 
 In the years since the discovery of α-carboxylase, studies have been performed on 
many other ThDP-dependent enzymes concurrently with those on the cofactor itself. Today, 
members of the ThDP-dependent superfamily have been identified belonging to 4 out of the 7 
enzyme commission classifications. These include: oxidoreductases (1.X.X.X), transferases 
(2.X.X.X), hydrolases (3.X.X.X), and lyases (4.X.X.X). Indeed, enzymes in this superfamily 
catalyze a wide array of reactions including decarboxylations, carboligations, formation of 
carbon-nitrogen bonds, formation of carbon-oxygen bonds, and formation of carbon-sulfur bonds 
(18). 
 As seen in Figure 1.4, these enzymes function on a diverse range of substrates, 
forming even more diverse range of products. What is especially intriguing about this is that all 
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the reactions proceed through, in essence, the same reaction intermediate, even when forming 
different products from identical substrates.  
 
 
Figure 1.4: Reactions catalyzed by ThDP-dependent enzymes. 
Reproduced from Pohl et al. (18). 
1.2.1 General structural features of ThDP-dependent enzymes 
Structurally, members of the ThDP-dependent family are quite similar. Each enzyme 
contains at least two domains, the pyrimidine-binding domain (Pyr), and the diphosphate-binding 
domain (PP). Barring one exception, sulfopyruvate decarboxylase (19), these domains are fused 
in one contiguous protein chain (20). In addition to the PP and Pyr domains, most enzymes in this 
family contain at least one more domain. In fact, sulfopyruvate decarboxylase (19) and 
phosphonopyruvate decarboxylase (21) are the only two known ThDP-dependent enzymes that do 
not contain an additional domain (22). 
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Many ThDP-dependent enzymes exist as either a dimer, or as a tetramer “dimer of dimers” 
in solution (Figure 1.5). With only two exceptions, pyruvate ferredoxin oxidoreductase (PFOR) 
(23) and d-xylulose-5-phosphate synthase (24), the active site is found at a dimer interface. The 
active site comprises residues from both the Pyr domain, and the PP domain. As the names imply, 
residues from the PP domain bind the diphosphate group of ThDP, while residues from the Pyr 
domain bind the pyrimidinyl group. By symmetry, two active sites are formed at each dimer 
interface (25).  
Figure 1.6 shows the general architecture of the ThDP binding site. Even though the overall 
structure of the active sites is similar between members of this family, there are very few conserved 
residues among them. Only the diphosphate binding motif (GDG(X)26-24NN) (26) is universally 
conserved. However, most also contain a glutamate residue located near N1’ of the cofactor 
pyrimidine ring (27,28).  
Inspection of the first X-ray crystal structures of ThDP-dependent enzymes, including PDC 
(29,30), pyruvate oxidase (31), and transketolase (TK) (32), revealed that the ThDP cofactor binds 
in a strained V-conformation (33). This conformation is conserved and has been observed in every 
cofactor bound structure of a ThDP-dependent enzyme to date. It was postulated that the V-
conformation was held in place by a commonly observed hydrophobic residue in the active site, 
often leucine, isoleucine, or methionine (34). While mutation of this residue did result in reduction 
of reaction rate, it was shown that it is not due to loss of the V-conformation indicating that the 
hydrophobic residue is not essential for maintaining this conformation (35). 
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Figure 1.5: Typical A) dimeric (PDB ID: 5IMS) and B) tetrameric (PDB 
ID: 1OZF) structures of ThDP-dependent enzymes. Two active sites are 
formed at the interface of the green and orange monomers and the interface 
of the pink and blue monomers. 
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Figure 1.6: Typical ThDP binding site with bound ThDP. Residues from both the 
Pyr domain (orange) and the PP domain (green) form the ThDP binding pocket. 
The conserved hydrophobic residue and the conserved glutamate are also shown. 
Figure prepared in UCSF Chimera (36) using PDB ID: 5DX6. 
1.2.2 Activation of enzyme-bound ThDP 
Studies on these enzymes, as well as the ThDP cofactor, itself posed a major question about 
thiamin catalysis in enzymes. ThDP is a true catalyst, i.e., it is able to catalyze reactions without 
the requirement of being bound to an enzyme. Therefore, what is the purpose of the enzyme if the 
cofactor can catalyze the reaction without it? 
One basic answer to this question quickly became apparent; the protein contributes 
significant enhancement to the reaction rate. Kemp and O’Brien (37) demonstrated that the rate of 
decarboxylation catalyzed by PDC was much faster than what would be possible by the cofactor 
alone, even at very high ThDP concentrations. This was explained by the fact that, while H-D 
exchange on C2 was reasonably fast, the rate of protonation of the ylid was found to be much 
faster, bordering on the limits of diffusion control. This meant that, at equilibrium, the 
concentration of the reactive ylid in solution is extremely low, and therefore could not provide rate 
enhancements as great as those observed in the enzymatic reactions (37,38). Indeed, PDC was 
25 
 
shown to catalyze the decarboxylation of pyruvate as much as 104 times faster than thiamin alone 
(39). 
The size of the rate enhancement led to many hypotheses on how the enzyme managed to 
increase the rate of transformation so drastically. Proposals included enzymatic stabilization of the 
ylid (37,40), rapid deprotonation of C2 (41), and a concerted model of deprotonation with 
simultaneous addition of the substrate to the cofactor  (42,43). The debate continued until Kern et 
al. (44,45) provided evidence that showed that the rate of H-D exchange at C2 is sufficiently 
increased when the cofactor is bound to an enzyme to justify the measured enzymatic rates of 
catalysis. They went on to test a previously proposed mechanism through which the enzymes could 
accomplish this task. Based on earlier observations of the conserved glutamate residue that 
interacts with the 1’ nitrogen of the pyrimidine ring, it was proposed that this residue somehow 
promotes deprotonation of C2 (33). In support of this, mutagenesis of the glutamate residue 
resulted significant reductions in both the rate of deprotonation at C2 and in overall reaction rate,  
indicating that the residue is indeed important for activation of the cofactor. To date, only one 
known ThDP-dependent enzyme, glyoxylate carboligase, lacks this otherwise conserved residue 
(27,28).  
In the same study, the importance of the 4’ amino group was also investigated. The 
introduction of 4’-desamino ThDP showed a similar decrease in both the rate of C2 deprotonation 
and overall reaction rate. Taken together, these results indicated that the conserved glutamate 
residue, the 1’ nitrogen and the 4’ amino group are all important for the reaction rate enhancement 
observed in ThDP-dependent enzymes (44).  
The explanation of how these factors work in concert to promote deprotonation of C2 
involved one other factor, the V-conformation of enzyme-bound ThDP. It was observed that this 
conformation places the 4’ amino group in sufficiently close proximity to the C2 hydrogen to allow 
for proton abstraction. When considered in conjunction with the role of the conserved glutamate, 
the 1’ nitrogen, and the 4’ amino group, a more complete understanding of how the enzymes 
promote ThDP-dependent catalysis became clear. The conserved glutamate stabilizes the imino 
(IP) tautomeric form of ThDP. Concomitantly, the 4’ amino group, now a 4’ imino group, is 
positioned sufficiently close to close to C2 to allow for proton abstraction, resulting in the 
formation of the ThDP ylid (3,34,44,46).  
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Figure 1.7 shows the many states of enzyme-bound ThDP including a tricyclic 
dihydrothiachrome form. A version of this form of ThDP was first observed bound to an enzyme 
containing a trapped reaction intermediate where it was proposed to be directly involved in the 
catalytic mechanism (47). However, a similar tricyclic form of ThDP was later shown to act as a 
potential kinetic trap in at least some ThDP-dependent enzymes (48). A further analysis and 
discussion of this form of ThDP can be found in Chapter 4. 
   
 
Figure 1.7: Formation of the ThDP ylid. Reproduced from Planas et al. (49). 
1.2.3 Reactions of ThDP-dependent decarboxylases 
The largest family of ThDP-dependent enzymes is the decarboxylase family (25), with the 
most well-studied of these, PDC, often referred to as the archetypal ThDP-dependent enzyme (50). 
As such, many of the following discussions will focus around studies performed on this enzyme. 
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1.2.3.1 Decarboxylation reactions 
The simplest decarboxylases catalyze the decarboxylation of an α-ketoacid to form an 
aldehyde and carbon dioxide. A prime example of this is the reaction catalyzed by PDC, in which 
pyruvate is decarboxylated to provide acetaldehyde and carbon dioxide (Figure 1.8). 
 
 
Figure 1.8: Decarboxylation reaction catalyzed by PDC. 
  
Initially, reaction occurs through the same basic steps as the mechanism proposed by 
Breslow for the benzoin condensation (Figure 1.3 A). However, instead of attack on a second 
substrate by the Breslow intermediate, otherwise known as the carbanion/enamine or the “activated 
aldehyde”, the intermediate is rapidly protonated (Figure 1.9). The basic steps include: i) attack on 
the pyruvate substrate by the ThDP ylid forming the first tetrahedral intermediate 2-α-lactylThDP 
(LThDP), ii) decarboxylation to form the activated aldehyde, iii) protonation of the activated 
aldehyde, forming the second tetrahedral intermediate, 2-α-hydroxyethylThDP (HEThDP), and iv) 
release of acetaldehyde and regeneration of the ThDP ylid (51). 
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Figure 1.9: Consensus mechanism of acetaldehyde formation by PDC. 
1.2.3.2 Carboligation reactions 
Not all members of the decarboxylase family catalyze solely decarboxylation reactions. 
Many ThDP dependent decarboxylases are able to catalyze carbon-carbon bond formation as well. 
Typically, these occur through attack on a first α-ketoacid substrate, termed the donor substrate. 
However, instead of protonation, the enamine attacks a second substrate, termed the acceptor 
substrate (52). These carboligation reactions are directly analogous to the benzoin condensation 
previously discussed.  
Most common among these reactions is the condensation of two α-ketoacids, one α-
ketoacid and an aldehyde, or two aldehydes. For each of the substrate combinations listed, the 
product is a chiral α-hydroxyketone (52). These α-hydroxyketone products have found utility in 
synthesis applications including that of antifungal compounds (53), and vitamin E (54). The oldest 
reported, and perhaps the most well known of these transformations is the use of PDC to form (R)-
phenylacetyl carbinol ((R)-PAC). The transformation is the result of condensation of pyruvate with 
benzaldehyde (Figure 1.10), and was originally discovered by adding both glucose and 
benzaldehyde to fermenting yeast cultures (55). In fact, this transformation is the subject of the 
first known patent for green chemistry.  
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(R)-PAC is an important compound in pharmaceutical synthesis as it can be easily 
converted to ephedrine through reductive amination using methylamine (55), or to 
phenylpropanolamine, another common pharmaceutical compound, by reaction with 
hydroxylamine followed by treatment with lithium aluminum hydride (56). 
 
 
Figure 1.10: Synthesis of ephedrine using PDC to form (R)-PAC. 
 
Over time, interest in these carboligation reactions has grown (52) and many other 
reactions have been reported. Discovery and modification of ThDP-dependent decarboxylases 
such as phenylpyruvate decarboxylase (57-59), benzoylformate decarboxylase (BFDC) (60-62), 
as well as the identification and utilization of pyruvate decarboxylases from new sources (63-68), 
has brought about a large expansion of synthetic possibilities. Some of this improvement is 
obvious, in that these new enzymes accept different substrates, or can be engineered to do that.  
A different approach has been to develop catalysts with altered stereospecificity. For 
example, the synthesis of ephedrine described above used S. cerevisiae PDC to convert a mixture 
of pyruvate (or acetaldehyde) and benzaldehyde into (R)-PAC. More recently, a combination of 
site-directed and random mutagenesis converted the PDC from Acetobacter pasteurianus, ApPDC, 
into a variant that would catalyze the formation of (S)-PAC in >97% enantiomeric excess (ee) 
(67,68). These two reactions used pyruvate (or acetaldehyde) as the donor and benzaldehyde as 
the acceptor. Under the same reaction conditions, BFDC uses benzoylformate (or benzaldehyde) 
as the donor and acetaldehyde as the acceptor to provide (S)-2-hydroxypropiophenone ((S)-HPP) 
in good ee (52), whereas ThDP-dependent decarboxylase, KdcA, provides >90% (R)-HPP (69). If 
benzaldehyde was used as both donor and acceptor, BFDC affords (R)-benzoin as the sole product 
(52). ApPDC proved to be an adaptable enzyme as variants were prepared that catalyzed formation 
of (S)-benzoin (70). Taken together, these enzymes or variants, all of which are formally 
decarboxylases, have the ability to form all regio- and stereoisomers from a mixture of 
acetaldehyde and benzaldehyde (Figure 1.11). 
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Figure 1.11: Formation of PAC, HPP, and benzoin from acetaldehyde and 
benzaldehyde by ThDP-dependent decarboxylases. 
1.2.3.3 Pyruvate-utilizing ThDP-dependent decarboxylases 
It should be noted that the carboligation reactions described in the previous section have 
all been catalyzed by ThDP-dependent enzymes whose principal function is decarboxylation. 
However, for many members of this family, decarboxylation is only the first part of the reaction 
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they catalyze. As an example of this diversity, it has been shown that there are at least 6 different 
enzymes that form unique products using only pyruvate as the donor substrate (18). These enzymes 
catalyze the formation of carbon-hydrogen bonds, carbon-carbon bonds, carbon-oxygen bonds, 
and carbon-sulfur bonds (Figure 1.12). Interestingly, the reactions all go through the identical 
intermediates up to the formation of the carbanion/enamine. It is at this point that the reactions 
diverge and lead to a range of products. 
 
 
Figure 1.12: Reactions catalyzed by pyruvate-utilizing ThDP-dependent decarboxylases. 
Abbreviations used: PDC, pyruvate decarboxylase; PDH, pyruvate dehydrogenase complex; 
ALS, acetolactate synthase; AHAS, acetohydroxyacid synthase; POX, pyruvate oxidase; 
DXPS, deoxyxylulose-5-phosphate synthase. 
1.3 Acetolactate synthase and acetohydroxyacid synthase 
For some members of the ThDP-dependent decarboxylase family, carboligation is their 
primary function. Two examples of these are acetolactate synthase (ALS), and acetohydroxyacid 
synthase (AHAS). These enzymes catalyze the formation of (S)-acetolactate from two molecules 
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of pyruvate. Additionally, AHAS readily catalyzes the formation of (S)-acetohydroxybutyrate 
(Figure 1.13) from one molecule of pyruvate and one molecule of α-ketobutyrate (47,71-74).  
Although these enzymes catalyze the same reaction, they are quite different. In addition to 
having distinct physiological roles, these differences include reaction kinetics, substrate profile, 
structure, and cofactor requirements.  
 
 
Figure 1.13: Reactions catalyzed by ALS and AHAS in vivo. 
 
AHAS catalyzes the first step of valine and isoleucine biosynthesis through the formation 
of (S)-acetolactate and (S)-acetohydroxybutyrate, respectively (71,72). The biosynthetic pathway 
for isoleucine and valine is discussed in detail in Chapter 5. Conversely, ALS catalyzes the 
formation of (S)-acetolactate in the first step of the 2,3-butanediol pathway (Figure 1.14). 
The biosynthesis of isoleucine and valine is an anabolic pathway, and the purpose it serves 
is clear; these compounds are required for protein synthesis. Accordingly, AHAS is highly 
expressed during the exponential phase of cell culture growth (75). Conversely, synthesis of 2,3-
butanediol is part of a catabolic pathway, and its purpose is less clear. However, there are two main 
proposals: i) it is an alternative to mixed acid fermentation by forming a less acidic product, and 
ii) regulation of cellular NAD+/NADH ratios upon the exhaustion of a carbon source (76). Support 
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for both is provided in that expression of ALS has been shown only in stationary phase cultures 
undergoing anaerobic mixed acid fermentation (75).  
The involvement of AHAS in anabolism and ALS in catabolism led to many references to 
them in the literature as the “anabolic ALS” and the “catabolic ALS”. Other times, both enzymes 
were simply referred to as ALS. To prevent confusion, the terms AHAS and ALS were adopted 
and will be the standard terminology used throughout this dissertation. 
 
 
Figure 1.14: Formation of 2,3-butanediol by enzymes on the bud operon. 
ALDC: acetolactate decarboxylase, 23BDH: 2,3-butanediol dehydrogenase. 
 
 
Despite the differences between them, both ALS and AHAS are thought to catalyze the 
formation of acetolactate through the same mechanism. The reaction (Figure 1.15) comprises four 
main steps, the first two of which are identical to the reaction catalyzed by PDC: i) attack by the 
ThDP ylid on the α-carbonyl carbon on pyruvate (donor substrate) forming LThDP, ii) 
decarboxylation of LThDP forming the activated aldehyde, iii) attack by the activated aldehyde on 
the acceptor substrate forming the second tetrahedral intermediate, acetolactylThDP (ALThDP), 
and iv) release of the acetolactate product and regeneration of the ThDP ylid. In AHAS, α-
ketobutyrate can be used as the acceptor substrate to provide acetohydroxybutyrate. While early 
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evidence for the mechanism of acetaldehyde formation in PDC was provided by synthesizing 
proposed intermediates and testing their reactivity (77), observation of individual reaction 
intermediates by NMR provided evidence for the mechanism of formation of acetolactate in AHAS 
(78-80).  
 
Figure 1.15: Mechanism of acetolactate and acetohydroxybutyrate formation by 
AHAS and ALS. 
 
 
Notwithstanding the ability of AHAS to readily form acetohydroxybutyrate, one of the 
most interesting differences between these enzymes is that AHAS binds FAD (81), while ALS 
does not (82,83). Initially, the role of FAD in AHAS was thought to be structural (81,84). Recently, 
however, a new mechanism of acetolactate formation by the AHAS from Saccharomyces 
cerevisiae (ScAHAS) was proposed, which suggests a role for FAD in which it is directly involved 
in the reaction mechanism (85). The new mechanism potentially sheds light on the previous 
observations that reduced FAD is required for AHAS activity (85-89), as the first step of the 
reaction directly involves fully reduced FAD. Finally, the proposed mechanism potentially 
provides insight into the mechanism through which popular sulfonylurea and imidazolinone 
herbicides show time-dependent inactivation of AHAS (90,91). This new reaction mechanism and 
the inactivation of AHAS by these herbicides are discussed in detail in Chapter 5. 
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1.4 Summary of research covered in this dissertation  
The main focus of the work presented in this dissertation is on determining the differences 
between two similar enzymes, ALS and AHAS, from the same organism, Klebsiella pneumoniae. 
In Chapter 3, both enzymes were kinetically characterized. Of primary interest were: kinetic 
profile, substrate specificity, and product distribution. In Chapter 4, three X-ray crystal structures 
were solved after crystals were soaked with 3 different compounds, and the effect each has on the 
enzyme structure is discussed. Additionally, a mutagenesis study prompted by both structural and 
kinetic observations to investigate a unique feature of ALS is also described. Finally, in Chapter 
5, a mutagenesis study was performed and a growth complementation assay was implemented to 
determine the ability of ALS to function in place of AHAS in vivo. 
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CHAPTER 2. MATERIALS AND METHODS 
2.1 Materials 
NADH, IPTG, yeast alcohol dehydrogenase (YADH), 2-keto acids, and diketones were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Nickel-nitrilotriacetic acid (Ni-NTA) 
agarose resin was purchased from Qiagen (Valencia, CA, USA). Buffers and other reagents were 
purchased from either Sigma-Aldrich or Fisher Scientific (Pittsburg, PA, USA) and were of the 
highest commercially available grade.  
Genomic DNA from K. pneumoniae str 7561 was purchased from the ATCC (Manassas, 
VA, USA). E. coli strains MI168, MI253, MI262, and FD1062 were obtained from the Coli 
Genetic Stock Center (New Haven, CT, USA). The plasmid vectors pET28a, pCRBlunt and 
pBAD-Myc/HisA, and E. coli strains TOP10 and BL21(DE3) were available from laboratory 
stocks. Restriction enzymes were purchased from New England Biolabs (Ipswich, MA, USA). Pfu 
Ultra was purchased from Stratagene (San Diego, CA, USA). All primers were designed according 
to the QuikChange protocol (Agilent Technologies, Santa Clara, CA, USA) and synthesized by 
Integrated DNA technologies (Coralville, IA, USA). DNA sequencing was carried out at the 
University of Michigan Sequencing Core Facility (Ann Arbor, MI, USA).  
Crystal screening kits, crystallization trays, and silanized coverslips were purchased from 
Hampton Research (Aliso Viejo, CA, USA). Flow valves for diketone extraction were purchased 
from Cole-Parmer (Vernon Hills, IL, USA), and multiwell plates for cell growth assays were 
purchased from USA Scientific (Ocala, FL, USA). 
2.2 Construction of expression vectors 
2.2.1 Cloning and construction of expression vector pET28aKpALS-HisN 
Plasmid pTL8 carrying the budB gene was a kind gift from Prof. Hwan-You Chang 
(Institute of Molecular Medicine, National Tsing Hua University, Hsinchu City, TW). 
Construction of the pET28aKpALS-HisN expression vector was done by Prof. Michael McLeish, 
and was available for use in the laboratory. 
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2.2.2 Construction of expression vector pBADKpALS*-HisN 
An internal restriction site for NcoI was removed from the pET28aKpALS-HisN 
expression vector by PCR mutagenesis. The silent mutation resulted in expression vector 
pET28aKpALS*-HisN. This vector was then digested with Nco1 and the gene encoding KpALS 
was ligated into pBAD/Myc-HisA that had been previously digested with Nco1 resulting in the 
pBADKpALS*-HisN expression vector. 
2.2.3 Cloning and construction of expression vector pBADKpIlvGM-Nde 
The gene encoding for KpAHAS was amplified from K. pneumoniae str. 7561 gDNA 
(ATCC BAA-2146D-5) by PCR. Restriction sites for NdeI and HindIII were engineered at the N-
terminus and C-terminus, respectively. The PCR product was ligated into the pCRBLUNT vector 
resulting in pCRBKpIlvGM. Mutagenesis was then performed on the pCRBKpIlvGM plasmid to 
remove an NdeI site internal to the ilvGM gene resulting in pCRBKpIlvGM-Nde. Concomitantly, 
PCR mutagenesis was performed on expression vector pBAD-Myc/HisA to remove an extraneous 
NdeI site in the vector resulting in pBAD (-NdeI). Following this, PCR mutagenesis was used to 
introduce an Nde1 restriction site in place of the Nco1 and KpnI restriction sites in the multiple 
cloning site of the pBAD (-NdeI) vector resulting in pBAD/Nde. The pCRBKpIlvGM-Nde and 
pBAD/Nde vectors were digested with NdeI and HindIII, and the KpIlvGM-Nde fragment was 
ligated into the digested pBAD/Nde vector resulting in the pBADKpIlvGM-Nde expression vector. 
2.2.4 Construction of expression vector pET28aKpIlvGM-Nde 
The pBADKpIlvGM-Nde vector was digested with NdeI and HindIII. The KpIlvGM-Nde 
fragment was then ligated into the pET28a vector that was previously digested with NdeI and 
HindIII, resulting in the pET28aKpIlvGM-Nde expression vector. 
2.2.5 Site-directed mutagenesis of KpALS 
Mutagenesis was performed on either the pET28aKpALS*-HisN or the pBADKpALS*-
HisN expression vectors. Site-directed mutagenesis was performed according to the QuikChange 
mutagenesis protocol (Agilent) using Pfu polymerase. Primers used in mutagenesis are listed in 
the chapters in which the mutants are discussed. Restriction enzyme DpnI was used to digest 
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template DNA prior to transformation into chemically competent One Shot TOP 10 chemically 
competent cells. Each plasmid was sequenced over the entire KpALS gene after mutagenesis to 
confirm that only desired mutations were introduced during PCR. 
2.3 Protein expression and purification 
2.3.1 Expression of recombinant proteins 
Following transformation of the appropriate vector into E. coli strain BL21(DE3), over-
expression of 6x-histidine tagged recombinant KpALS and KpAHAS was carried out in either LB 
media or auto-induction media. In LB, production of the recombinant protein was induced by 
addition of 1 mM IPTG to the culture during the exponential growth phase. Following induction, 
cultures were grown at room temperature for 18-20 hours. Alternatively, for expression in auto-
induction media, cultures were grown at 30 °C for 48 hours with rapid (275 rpm) shaking. In both 
cases cells were harvested by centrifugation and resuspended in 40 mL of Buffer A (50 mM sodium 
phosphate pH 7.0 or 8.0 containing 300 mM NaCl, and 10 mM imidazole). Resuspended cells were 
then stored at -80 °C until further use. 
2.3.2 Purification of recombinant proteins 
All purification steps were conducted at 4 °C. Frozen cells were thawed and incubated on 
ice with lysozyme (200 μg/mL) and DNase (5 μg/mL) for 30 minutes to lyse the cells. Cells were 
further lysed by sonication (2 x 90 s bursts at 30% duty cycle with a 90 s rest period between 
bursts) using a Branson Sonifier 450 sonicator (Danbury, CT, USA). Cellular debris was removed 
by two 30-minute centrifugation steps at 20,000g. Cell free extract (CFE) was loaded onto a 
Ni-NTA agarose column pre-equilibrated with Buffer A using a Biologic LC system (Bio-Rad, 
Hercules, CA, USA). The column was then washed with 10 column volumes of Buffer A and 5 
column volumes of Buffer B (50 mM sodium phosphate pH 7.0 or 8.0, 300 mM NaCl, 20 mM 
imidazole). Protein was eluted with 5 column volumes of Buffer C (50 mM sodium phosphate pH 
7.0 or 8.0, 300 mM NaCl, 250 mM imidazole). Fractions (5 mL) were collected from both the 
wash and elution steps. Initially the absorbance at 280 nm was used to determine which fractions 
contained protein and the result was confirmed by SDS-PAGE. Fractions containing protein were 
combined and concentrated to 3 mL using centrifugation filters with a 50k Da molecular weight 
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cutoff (Amicon Ultra, EMD Millipore, Burlington, MA, USA). Elution buffer was then exchanged 
for ALS (50 mM potassium phosphate, pH 7.0, 1 mM MgCl2, 0.5 mM ThDP, 10% glycerol) or 
AHAS (50 mM potassium phosphate, pH 8.0, 1 mM MgCl2, 0.5 mM ThDP, 2 μM FAD, 10% 
glycerol) storage buffer using an Econo-Pac DG10 desalting column (Bio-Rad). Purity was 
assessed by SDS-PAGE and protein concentration was determined either by absorbance at 280 nm 
or by Bradford Assay using BSA as a standard (1). Molar extinction coefficients were calculated 
using the EXPASY ProtParam tool (2). 
2.4 Kinetic characterization studies 
2.4.1 Steady-state analysis of KpALS 
Purified KpALS variants were kinetically characterized using circular dichroism (CD) 
spectropolarimetry on a Jasco J-810 spectropolarimeter. Formation of (S)-acetolactate was 
followed at 310 nm at which (S)-acetolactate has a molar ellipticity (θ) of 3000 deg×cm2/dmol (3). 
A typical reaction mixture contained buffer (100 mM sodium acetate, potassium phosphate, or 
MES pH 6.0), 1 mM MgCl2, 0.5 mM ThDP, and pyruvate (1-125 mM) in a final volume of 1 mL. 
Reactions were carried out at 30 °C over a 5-minute period and reactions were initiated by the 
addition of enzyme. Assays were carried out in triplicate and the steady-state kinetic parameters 
were determined by fitting the initial rate data to the Michaelis-Menten equation (Equation 2.1), 
or the Hill equation (Equation 2.2) using the Enzyme Kinetics package in SigmaPlot 12.5 
(Systat Software, Inc.). 
Equation 2.1:  𝑣 =
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑚+[𝑆]
 
Equation 2.2:   𝑣 =
𝑉𝑚𝑎𝑥[𝑆]
𝑛
𝑆05
𝑛 +[𝑆]𝑛
 
2.4.2 Steady-state analysis of KpAHAS 
A Jasco J-810 spectropolarimeter was used to obtatin steady-state kinetic data for 
KpAHAS. The formation of (S)-acetolactate (θ = 3000 deg×cm2/dmol) and 
(S)-propiohydroxybutyrate (θ  =  2640 deg×cm2/dmol) was measured at 310 nm and 300 nm, 
respectively (3). A typical reaction mixture contained buffer (100 mM potassium phosphate, 
potassium phosphate and acetate, or HEPES pH 8.0), 1 mM MgCl2, 0.5 mM ThDP, 2 μM FAD, 
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and varying concentrations of pyruvate or α-ketobutyrate in a total volume of 1 mL. Reactions 
were carried out at 30 °C and were initiated by addition of KpAHAS. Assays were carried out in 
triplicate and the steady-state kinetic parameters were determined by fitting the initial rate data to 
the Michaelis-Menten equation (Equation 2.1). 
2.4.3 Assay of decarboxylation activity 
 The decarboxylase activity of KpALS and KpAHAS was determined using a 
coupled assay in which acetaldehyde formation was measured by following the disappearance of 
NADH at 340 nm (ε = 6220 L×mol-1×cm-1) (4) on a Varian Cary 50 UV/Vis spectrophotometer 
(Agilent). The assay contained pyruvate, 200 μM NADH, 80 U YADH, 100 mM sodium acetate 
buffer pH 6.0, 0.5 mM ThDP, and 1 mM MgCl2 in a final volume of 1 mL. The reactions were 
carried out at 30 °C and were initiated by addition of enzyme.  
2.4.4 Inhibition of KpALS by β-fluoropyruvate 
 Studies on inhibition of KpALS by β-fluoropyruvate were performed using the 
standard CD assay in which formation of (S)-acetolactate was followed at 310 nm. Each reaction 
contained 100 mM sodium acetate pH 6.0, 0.5 mM ThDP, 1 mM MgCl2, and pyruvate (5-50 mM) 
and β-fluoropyruvate (0-125 μM). Reactions were carried out at 30 °C and were initiated by 
addition of KpALS. Assays were carried out in triplicate and the steady-state kinetic parameters 
and inhibition constants were determined by fitting the initial rate data to the equations for 
competitive (Equation 2.3), uncompetitive (Equation 2.4), non-competitive (Equation 2.5), and 
mixed (Equation 2.6) inhibition. The type of inhibition was determined by the best fit to the data.  
Equation 2.3:   𝑣 =
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑚(1+
[𝐼]
𝐾𝑖
)+[𝑆]
 
Equation 2.4:  𝑣 =
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑚+(1+
[𝐼]
𝐾𝑖
)[𝑆]
 
Equation 2.5:   𝑣 =
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑚(1+
[𝐼]
𝐾𝑖
)+(1+
[𝐼]
𝐾𝑖
)[𝑆]
 
Equation 2.6:   𝑣 =
𝑉𝑚𝑎𝑥[𝑆]
𝐾𝑚(1+
[𝐼]
𝐾𝑖
)+(1+
[𝐼]
𝐾𝑖
′)[𝑆]
  where Ki ≠ Ki′ 
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2.4.5 Inhibition of KpAHAS by β-fluoropyruvate 
 Studies on inhibition of KpALS by β-fluoropyruvate were performed using the 
standard CD assay in which formation of (S)-acetolactate was followed at 310 nm. Each reaction 
contained 100 mM potassium phosphate pH 8.0, 0.5 mM ThDP, 1 mM MgCl2, 2 μM FAD, 
pyruvate (1-10 mM) and β-fluoropyruvate (0-125 μM). Reactions were carried out at 30 °C and 
were initiated by addition of KpAHAS. Assays were carried out in triplicate and the steady-state 
kinetic parameters and inhibition constants were determined by fitting the initial rate data to the 
equations for competitive (Equation 2.3), uncompetitive (Equation 2.4), non-competitive 
(Equation 2.5), and mixed (Equation 2.6) inhibition. The type of inhibition was determined by the 
best fit to the data. 
2.4.6 Inhibition of KpALS by chlorsulfuron 
 Studies on inhibition of KpALS by chlorsulfuron were performed using the CD 
assay (see Section 2.4.1). Each reaction was made to a final volume of 1 mL and contained 100 
mM sodium acetate pH 6.0, 0.5 mM ThDP, 1 mM MgCl2, and varying concentrations of pyruvate 
(3-30 mM) and chlorsulfuron (0, 400 nM). The stock solution of chlorsulfuron was dissolved in 
DMSO to aid in solubility and stability. Assays were carried out in triplicate and the steady-state 
kinetic parameters and inhibition constants were determined by fitting the initial rate data to the 
equations for competitive (Equation 2.3), uncompetitive (Equation 2.4), non-competitive 
(Equation 2.5), and mixed (Equation 2.6) inhibition. The type of inhibition was determined by the 
best fit to the data. 
2.4.7 Inhibition of KpAHAS by chlorsulfuron 
Studies on inhibition of KpAHAS by chlorsulfuron were performed similarly to those 
performed on KpALS. Each reaction contained 100 mM potassium phosphate, 0.5 mM ThDP, 1 
mM MgCl2, 2 μM FAD, and varying concentrations of pyruvate (1-12 mM) and chlorsulfuron (0, 
400 nM). Assays were carried out in triplicate and the steady-state kinetic parameters and 
inhibition constants were determined by fitting the initial rate data to the equations for competitive 
(Equation 2.3), uncompetitive (Equation 2.4), non-competitive (Equation 2.5), and mixed 
(Equation 2.6) inhibition. The type of inhibition was determined by the best fit to the data. 
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2.5 Analysis of product distribution by KpAHAS 
2.5.1 Enzymatic reactions and formation of diketones 
 Reactions and conversion of products to diketones was performed as described in 
the previously reported procedure (5). Reactions contained 100 mM potassium phosphate pH 8.0, 
0.5 mM ThDP, 1 mM MgCl2, 2 μM FAD, and varying amounts of pyruvate and α-ketobutyrate in 
a final volume of 4 mL. Reactions were carried out at 30 °C, initiated by addition of KpAHAS and 
were allowed to continue for 5 minutes before quenching with H3PO4 to a pH of 4.0. A solution 
(5 mL) containing FeCl3 and FeSO4 was added to the quenched reaction mixture to a final Fe2+ 
and Fe3+ concentration of 150 μM. The mixture was then heated to 80 °C for 10 minutes to convert 
the enzymatic reaction products, acetolactate and acetohydroxybutyrate, into 2,3-butanedione and 
2,3-pentanedione, respectively.  
2.5.2 Extraction of diketones for analysis 
 Following conversion of acetohydroxyacids to diketones, the solutions were cooled 
on ice for 10 minutes to prevent loss of volatile diketones. Once cooled, the reactions were 
transferred to an “air distillation” apparatus (see Chapter 3, Figure 3.6). The solutions were then 
heated to 60 °C while air flowed at a rate of 100 mL/minute through the reaction mixtures into a 
second tube containing 2 mL of ice-cold methanol. The air distillation was carried out for 25 
minutes to ensure efficient capture of diketone products. Following distillation, acetoin was added 
to the methanol/diketone mixture to a final concentration of 1 mM to act as an internal standard 
for GC-MS analysis. 
2.5.3 Analysis of extracted diketones by GC-MS 
 Diketone products were separated by gas chromatography using a 
30 m × 250 μm × 0.25 μm capillary column with a VF-23ms stationary phase (Agilent). Samples 
(1 μL) were injected using an Agilent 7693 autosampler. The inlet temperature was held at 250 °C 
and samples were injected using a 3:1 split ratio. Helium flow through the column was held at 1.89 
mL/minute. The starting column oven temperature was held at 40 °C held for 2 minutes. Oven 
temperature was then increased at a rate of 30 °C/min to a final temperature of 90 °C and held for 
2 minutes. The total run time for the separation was 5.4 minutes. Detection of compounds eluting 
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from the column was performed by mass spectrometry using an Agilent Technologies 5975C inert 
MSD with triple axis detector set to scan a mass range of 40 to 120 M/Z. Retention times for 2,3 -
butanedione, 2,3-pentanedione, 3,4-hexanedione, and acetoin were found to be 2.7 minutes, 3.4 
minutes, 4.0 minutes, and 4.8 minutes, respectively. The column heating method was developed 
using standards of 2,3-butanedione, 2,3-pentanedione, 3,4-hexandione, and acetoin (Sigma). Peaks 
were integrated using the ChemStation software, and peak areas were used to determine the 
quantity of each compound in the sample. Peak areas corresponding to 2,3-butanedione, 2,3-
pentanedione, and 3,4-hexanedione were normalized by division by the acetoin peak area in each 
sample to account for injection volume errors. Standard curves were constructed using a range of 
concentrations (0.05 mM – 1.0 mM) of each analyte. Each sample was analyzed at least three times 
and peak areas were reported as the average of the measurements. Where applicable, steady state 
kinetic parameters were determined by fitting the initial rate data to the Michaelis-Menten equation 
(Equation 2.1), or the Hill equation (Equation 2.2).  
2.6 Conversion of KpALS into a functional AHAS enzyme 
2.6.1 Mutagenesis of pBADKpALS*-HisN 
Site-saturation and site-directed mutagenesis was performed as previously reported (6) 
using the QuikChange site-directed mutagenesis protocol (Invitrogen). Site saturation variants 
were constructed using pBADKpALS*-HisN as the template. Degenerate primers were used to 
encode for all 20 amino acids at selected sites. The mix of mutated plasmids was transformed into 
One Shot TOP10 chemically competent cells and plated on LB/agarose for colony growth. 
Following overnight growth, colonies were mixed on the LB/agarose plate using 1 mL of LB 
media. The culture was brought to a volume of 3 mL then grown overnight at 37 °C. Plasmid DNA 
was isolated using a Zyppy Plasmid Mini-Prep kit (Zymo Research) then immediately transformed 
into E. coli strain MI262 (7) and cells were grown overnight on LB/agarose for growth 
complementation studies.  In some cases the isolated plasmid DNA mixture was stored at -20 °C. 
2.6.2 Growth complementation assay 
 Growth complementation studies were performed as described by Sikdar and Kim 
(8). Plasmids containing engineered KpALS variants as well as the control plasmids,  
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pBADKpALS*-HisN and pBADKpIlvGM-Nde, were transformed into E. coli MI262 cells and 
plated on LB agar containing ampicillin (7). The resultant colonies were picked and individually 
placed into 200 μL of LB media in 96-well plates. The plates were incubated while shaking at 37 
°C overnight. A Biotek ELx808 IU plate reader was used to monitor cell growth at 595 nm taking 
1 reading per hour. A small amount (<5 μL) of cell culture from overnight growth was transferred 
into the corresponding wells in a fresh 96-well plate containing M9 minimal media (6.8 g/L sodium 
phosphate dibasic, 5 g/L potassium phosphate monobasic, 0.5 g/L NaCl, 1 g/L NH4Cl, 2 mM 
MgSO4, 0.1 mM CaCl2, 0.4% glucose, pH 7.4) supplemented with 0.2 mM thiamine-HCl, and 25 
μg/mL each of 18 standard amino acids with the exception of valine and isoleucine. The minimal 
growth media was supplemented with valine or isoleucine as required. The plate containing the 
inoculated cultures was incubated for 24-48 hours at 37 °C and a reading at 595 nm was taken 
every 15 minutes. A sample was taken from any wells showing growth in the M9 minimal media, 
grown overnight in 3 mL of LB media, and plasmid DNA was isolated using a Zyppy Plasmid 
Mini-Prep kit. Purified plasmid DNA was then sent for DNA sequencing. 
2.7 Solution and analysis of KpALS crystal structures 
2.7.1 Crystallization of KpALS 
Crystals of KpALS were grown using the hanging drop diffusion method using conditions 
reported by Pang et al. (9,10). Storage buffer was exchanged for crystallization buffer (50 mM 
potassium phosphate pH 7.0, 1 mM ThDP, 1 mM MgCl2, 1 mM DTT) using an Econo-Pac DG10 
desalting column (Bio-Rad). The well solution consisted of 0.1 M sodium HEPES pH 7.5, 5-10% 
PEG8000 (w/v), and 3-12% ethylene glycol (v/v). Equal volumes of well solution and enzyme (10 
mg/mL) were pipetted onto a silanized glass cover slip and mixed. Crystallization trays were 
incubated at 4 °C and well-formed crystals appeared after 5-7 days. 
2.7.2 Ligand soaking experiments 
Crystals grown in the absence of ligand were used in soaking experiments with pyruvate, 
β-fluoropyruvate, and phosphonodifluoropyruvate. The experiments involving pyruvate and β -
fluoropyruvate were performed at the Advanced Photon Source at the Argonne National 
Laboratory (Argonne IL, USA).  
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For soaking with pyruvate, the crystals were placed in well solution supplemented with 
100 mM pyruvate and 30% (v/v) PEG600 as a cryoprotectant and allowed to incubate at 4 °C for 
5-10 seconds before being flash frozen in liquid nitrogen. In the β-fluoropyruvate experiments, 
Crystals were placed in well solution containing 50 mM β-fluoropyruvate and 30 % (v/v) PEG600 
as a cryprotectant and allowed to incubate at 4 °C for up to 5 minutes before being flash frozen.  
Soaking with phosphonodifluoropyruvate was accomplished by adding 20 mM 
phosphonodifluoropyruvate to drops containing formed KpALS crystals. The crystals were then 
incubated at 4 °C for an additional 2 weeks before being transferred to well solution containing 
30% (v/v) PEG600 as a cryprotectant and subsequently flash frozen.  
2.7.3 X-ray data collection and processing 
Diffraction data collection was carried out at 100 K at the GM/CA-CAT sector 23 beamline 
ID-B at the Advanced Photon Source at the Argonne National Lab (Argonne IL, USA). All data 
sets were indexed, scaled, and merged in the I121 space group using MOSFLM, Pointless, Aimless, 
and cTruncate in iMosflm (11). 
2.7.4 Structure solutions and refinements 
Molecular replacement was performed using phaser (12) in PHENIX (13). The search 
model was that of a previously published structure of KpALS (PDB ID: 10ZF) with bound ligands 
and water molecules removed. No further modification of the search model was necessary to obtain 
suitable molecular replacement solutions for each data set. Simulated annealing was performed 
using phenix.refine, and refinement was performed in both phenix.refine and Refmac (14,15). 
After each round of refinement, electron density was manually inspected and model building was 
performed in Coot (16). Refinement was carried out until the crystallographic and free R factors 
could no longer be improved, and model validity was checked using MolProbity (17,18). Images 
of protein structures were generated using PyMOL (19) or UCSF Chimera (20). 
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CHAPTER 3.  CHARACTERIZATION AND COMPARISON OF 
ACETOLACTATE SYNTHASE AND ACETOHYDROXYACID 
SYNTHASE FROM KLEBSIELLA PNEUMONIAE 
3.1 Introduction 
In 1955, Strassman et al. (1) published the first evidence showing that acetolactate is a 
direct precursor to the amino acid valine, and that it is derived solely from two molecules of 
pyruvate (Figure 1.13 A) in E. coli. Subsequently, it was shown that, in Aerobacter aerogenes, 
two distinct enzymes were able to form acetolactate (2). Both enzymes were found to only be 
active in the presence of a divalent cation and thiamin diphosphate (ThDP); yet, they exhibited 
different pH optima and inhibition patterns. The two enzymes responsible for this were termed the 
pH 6.0 acetolactate-forming enzyme and the pH 8.0 acetolactate-forming enzyme. Shortly after, it 
was then shown that the pH 8.0 enzyme from E. coli was also able to form acetohydroxybutyrate 
(Figure 1.13 B), a compound that had earlier been identified as an important precursor to isoleucine 
(3), from one molecule of pyruvate and one molecule of α-ketobutyrate (4). Finally, it was shown 
that the pH 8.0 enzyme has an absolute requirement for FAD in addition to ThDP (5). A couple of 
years later, the pH 6.0 enzyme from A. aerogenes was isolated in crystalline form by Störmer, who 
then characterized the enzyme (6). Interestingly, it showed no dependence on FAD, and with a 
catalytic rate of ~500 s-1, it was found to be much faster than the pH 8.0 enzyme (7,8). In fact, the 
pH 6.0 enzyme remains the fastest thiamin diphosphate-dependent enzyme known (9). 
For quite some time both enzymes were referred to as acetolactate synthases, despite the 
fact that they have been shown to have distinct properties. This terminology proved to be quite 
confusing and a new naming convention was proposed in which the pH 6.0 enzyme should be 
called acetolactate synthase (ALS), while the pH 8.0 enzyme should be called acetohydroxyacid 
synthase (AHAS) (10). 
Since the identification of AHAS as the enzyme responsible for synthesizing the 
acetolactate and acetohydroxybutyrate necessary for branched chain amino acid (BCAA) 
biosynthesis (1,3,4,11), orthologs of the enzyme have been studied from bacteria, fungi, and plants 
(10). Conversely, ALS enzymes have only been identified in bacteria, and the ALSs from A. 
aerogenes (6-8), Bacillus subtilis (12,13), Serratia marcescens (14), Enterobacter cloacae (15), 
and Klebsiella pneumoniae (9,16) have been studied to varying degrees. 
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3.1.1 General differences between AHASs and ALSs 
AHASs and ALSs show even more differences than simply optimal pH, catalytic rate, and 
dependence on FAD. First, the genes encoding for the enzymes are found on different operons. 
AHASs are generally found on the ilv operon, while ALSs are found the bud operon. The ilv operon 
contains the genes involved with BCAA production while the bud operon contains genes for the 
production of 2,3-butanediol. Indeed, AHASs and ALSs have been shown to be essential for the 
production of BCAAs and 2,3-butanediol, respectively (12,14,15,17-19).  
Second, AHASs generally contain two subunits, a catalytic and regulatory subunit, and 
form dimers in solution (20). Conversely, ALSs do not rely on a regulatory subunit, and form 
tetramers in solution (6,12,14,15).  
The presence of a regulatory subunit in AHAS is of particular interest because it has been 
implicated as the target for feedback inhibition by valine, a common feature among AHAS 
enzymes. Concomitantly, the lack of a regulatory subunit has been used to explain why some ALSs 
are generally resistant to such inhibition (10). However, this explanation seems insufficient after 
the discovery of the valine sensitive ALSs from S. marcescens and E. cloacae which do not rely 
on any known regulatory subunits (14,15). The source of valine sensitivity in these ALS enzymes 
has largely not been studied, and as such, is currently not well known. 
3.1.2 Substrate specificity in ALS and AHAS enzymes 
As acetolactate and acetohydroxybutyrate are chemically very similar, they are difficult to 
differentiate spectroscopically. As a consequence, the preference for pyruvate or α-ketobutyrate as 
an acceptor substrate in the AHASs was not known for quite some time. Additionally, whether 
ALSs were able to form any significant amount of acetohydroxybutyrate was also unclear. This 
was due primarily to the lack of specific detection methods for the two products.  
Formation of acetolactate and acetohydroxybutyrate is often detected by adaptation of the 
method developed by Westerfeld (21), which involves monitoring the formation of a colored 
complex after reaction of acetoin with creatine and naphthol. This was made possible by the 
discovery (22) that acetolactate and acetohydroxybutyrate undergo non-oxidative decarboxylation 
to acetoin and 3-hydroxy-2-pentanone, respectively, when heated under acidic conditions (Figure 
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3.1). As such, the method provided a reliable way to measure total concentrations of acetolactate 
and acetohydroxybutyrate in solution.  
One of the pitfalls of the Westerfeld method is the non-specific nature of the technique, i.e. 
both products produce the same colored complex. However, it was later discovered that 2 -aceto-
2-hydroxyacids undergo oxidative decarboxylation when heated in the presence of iron salts (23). 
The oxidative decarboxylation results in the formation of volatile diketones (Figure 3.1), which 
can then be separated for analysis by gas chromatography (GC). This technique allowed for the 
simultaneous quantification of both acetolactate and acetohydroxybutyrate (24), and has been 
recently adapted to allow for detection of a third possible product, propiohydroxybutyrate. 
Propiohydroxybutyrate is formed by the condensation of two molecules of α-ketobutyrate. The 
ability of at least one ALS and one AHAS to catalyze the formation of this product is discussed 
later in this chapter. 
Using the GC separation method, it was shown that AHASs generally show a strong 
preference for α-ketobutyrate over pyruvate as an acceptor substrate (24). That said, at least one 
enzyme, the AHAS I isozyme from E. coli, was shown to have almost no preference between the 
two acceptor substrates (25). Conversely, when the product distributions of the ALSs from B. 
subtilis and A. aerogenes were examined using this method, it was found that both enzymes largely 
favored the formation of acetolactate over acetohydroxybutyrate, indicating a strong preference 
for pyruvate as an acceptor substrate (26).  
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Figure 3.1: Conversion of acetolactate, acetohydroxybutyrate, and propiohydroxybutyrate to A) 
α-hydroxyketones, and B) diketones. 
3.1.3 Stereospecificity of ALS and AHAS enzymes 
Although acetolactate and acetohydroxybutyrate are both chiral, the stereochemistry of the 
products formed by ALS and AHAS was unknown for quite some time. However, in 1979, 
Sylvester and Stevens (27) showed that synthesis of valine and isoleucine requires the formation 
of (S)-acetolactate and (S)-acetohydroxybutyrate, respectively. By extension, this meant that the 
products formed by AHAS must be in the (S)- configuration. The stereospecificity of ALS 
remained unknown for another two decades until circular dichroism (CD) was used to show the 
product was also in the (S)- configuration (9,28) by comparison with products formed by AHAS.  
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To date, only crude extracts of an ALS and an AHAS from the same organism have been 
studied, and then only to determine the ratio of acetohydroxybutyrate and acetolactate formed (29). 
This chapter describes the kinetic characterization and comparison of the purified ALS and AHAS 
enzymes from Klebsiella pneumoniae (KpALS and KpAHAS). 
3.2 Kinetic analyses on KpALS and KpAHAS 
3.2.1 Expression and purification of KpALS and KpAHAS 
Construction of expression vectors, protein expression, and purification, were performed 
as described in Chapter 2. Both KpALS and KpAHAS were expressed as N-terminal 6x Histidine-
tagged variants and were purified by nickel affinity chromatography. Purity was determined by 
SDS-PAGE and protein concentration was determined by the Bradford assay (30). The catalytic 
(IlvG), and regulatory (IlvM) subunits of KpAHAS were co-expressed and co-purified, and all 
attempts to express and purify the catalytic subunit alone were unsuccessful. The molecular weight 
of each enzyme was calculated from their respective amino acid sequences by the ProtParam tool 
on the ExPASy server (31). The molecular weight of KpALS was found to be ~62.5 kDa, while 
the combined molecular weight of both subunits of KpAHAS was found to be ~70.5 kDa. 
3.2.2 Kinetic characterization of KpALS 
The kinetic characterization of the ALS from A. aerogenes (AaALS) by Störmer (7) 
showed that the enzyme was extremely sensitive to the buffer in which it is assayed. This included 
activation by acetate, and inhibition by phosphate and sulfate. Additionally, the enzyme was shown 
to exhibit Michaelis-Menten kinetics only in acetate buffer. All other buffers tested showed 
sigmoidal kinetics, indicating the requirement for substrate activation. A few years later, a similar 
analysis was performed on the ALS from B. subtilis (BsALS). The kinetics of this enzyme also 
showed a strong dependence on the buffer used (12). However, there were some interesting 
differences in the kinetic profiles of BsALS and AaALS.  
First, Michaelis-Menten kinetics were observed for BsALS in phosphate, but not acetate. 
Second, the pH optimum of BsALS was found to be ~7.0, while it was found to be ~6.0 for AaALS. 
Finally, while acetate was found to be the strongest activator of AaALS, isobutyrate was found to 
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be the strongest activator of BsALS. In both cases however, only compounds containing a 
carboxylate group showed any activating effect. 
In the present work, a similar study was proposed, with the steady-state kinetics of KpALS 
to be examined in three buffer systems: acetate, MES, and phosphate, all at pH 6.0 (Figure 3.2). 
Initially, kinetics were monitored using the colorimetric method (21). Later a CD method was 
employed, and the methods were compared.  
 
Figure 3.2: Plots of steady-state kinetic data for KpALS catalyzed formation of 
(S)-acetolactate in acetate (black), MES (green), and phosphate (blue) buffers at pH 
6.0. 
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Table 3.1: Michaelis-Menten parameters for KpALS in 50 mM of 
each acetate, MES, and potassium phosphate buffers at 30 °C. 
 kcat (s-1) Km (mM) kcat/Km (mM-1s-1) 
Acetate 310 ± 20 8 ± 1 39 
MES 290 ± 30 19 ± 1 15 
Phosphate 230 ± 20 37 ± 8 6 
 
The steady-state kinetic parameters (Table 3.1) for KpALS were found to be different in 
each buffer, and, in addition, the kinetics changed from Michaelis-Menten in acetate and MES to 
sigmoidal in phosphate (Figure 3.2).  The lowest Km and highest kcat values were observed in 
acetate buffer, while the highest Km value, or more correctly, S05 value, and lowest kcat value were 
observed in phosphate buffer. The buffers appear to affect Km values more than kcat values. In MES 
and acetate the kcat values were similar, but a ~2-fold increase in Km was observed going from 8 
mM in acetate to 19 mM in MES. While there was only a ~25% reduction in kcat, a ~4-5-fold 
increase was observed between the Km determined in acetate and the S05 value measured in 
phosphate buffer. 
 
 
Figure 3.3: Lineweaver-Burk plot showing competitive inhibition of KpALS by up 
to 50 mM phosphate at pH 6.0 when assayed in 50 mM acetate buffer at pH 6.0 
 
The change in kinetics prompted an investigation into potential inhibition by phosphate. 
As with AaALS, phosphate was shown to act as a competitive inhibitor ofKpALS (Figure 3.3). 
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Inhibition was observed in both acetate and MES buffers but there was a 4-fold difference in Ki 
values. Phosphate inhibition was stronger in acetate, with a Ki value of 10 mM, compared to that 
in MES where Ki was found to be 40 mM. 
After examining phosphate inhibition, the possibility of activation by acetate was also 
examined (Table 3.2), as, similar to AaALS, the fastest rates and best substrate binding were 
observed in acetate. Acetate activation was apparent in both MES and phosphate buffers. Just as 
was observed for phosphate inhibition, the effect was shown to be different in each buffer. 
However, the activating effects were found to be stronger in MES than in phosphate 
Table 3.2: Steady-state parameters obtained in acetate activation 
experiments in 50 mM MES and phosphate buffers. 
 kcat (s-1) Km (mM) kcat/Km (mM-1s-1) 
MES 290 ± 30 19 ± 1 15 
MES + Acetate 280 ± 40 9 ± 0.5 31 
Phosphate 230 ± 20 38 ± 8 6 
Phosphate + Acetate 200 ± 40 23 ± 7 9 
 
In MES, the addition of 50 mM acetate resulted in kinetic constants matching those found 
in acetate alone. This indicated that acetate does have some activating effect, at least on substrate 
binding, and that MES shows no apparent inhibition. As may be expected, Michaelis-Menten 
kinetics were observed in the presence and absence of acetate.  
Some evidence of acetate activation was also apparent in phosphate buffer, though the 
effect was less in magnitude than observed that in MES. As with activation in MES, acetate 
activation had no effect on kcat. Additionally, only a small effect on Km value was observed. Taken 
together, it is clear that acetate acts as an activator toward KpALS, and that the activating effect 
has little to no impact on kcat values, only on Km values. 
3.2.3 Using circular dichroism to detect (S)-acetohydroxyacids 
It has been shown that it is possible to monitor the formation of (S)-acetohydroxyacids 
directly by CD (28). The CD assay has multiple benefits over to the colorimetric method: i) it is a 
direct and continuous assay allowing for more precise rate measurement, ii) the assay is much 
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simpler in that only four components are required: substrate, buffer, enzyme, and water, and iii) 
the assay procedure is much faster as no quenching and derivatization reaction is required.  
Kinetic assays using this technique were performed as described in Chapter 2. Again, the 
assays were performed in acetate and phosphate buffers (Table 3.3) for comparison with data 
generated by the colorimetric method (21). While the values for kcat and Km obtained in the 
methods are not identical, it was found that they are within reasonable limits. In both methods, 
Michaelis-Menten kinetics were observed in acetate, while sigmoidal kinetics were observed in 
phosphate. 
Table 3.3: Steady-state parameters for KpALS using CD and colorimetric 
methods 
 kcat (s-1) Km (mM) kcat/Km (mM-1s-1) 
Acetate 310 ± 20 8 ± 1 39 
Acetate (CD) 430 ± 20 12 ± 2 36 
Phosphate 230 ± 20 38 ± 8 6 
Phosphate (CD) 190 ± 10 46 ± 2 4 
3.2.4 Kinetic characterization of KpAHAS 
In a similar study to that performed on KpALS, kinetic characterization of KpAHAS was 
carried out in two buffer systems: phosphate and HEPES at pH 8.0. Only minor variations in kcat 
and Km were observed between the assays with no evidence of sigmoidal kinetics observed in 
either buffer (Table 3.4). The effects of added acetate were also tested in phosphate buffer. 
Addition of acetate was shown to have minimal effect as the calculated values for kcat and Km 
remained effectively unchanged compared to the values obtained in phosphate alone (Table 3.4).  
Table 3.4: Steady-state parameters for KpAHAS in phosphate and HEPES buffers. 
 kcat (s-1) Km (mM) kcat/Km (mM-1s-1) 
Phosphate 7.5 ± 0.4 3.8 ± 0.4 2 
Phosphate + Acetate 3.5  ± 0.2 5.1 ± 1.0 0.7 
HEPES 4.5  ± 0.1 3.9 ± 0.4 1 
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3.2.5 Comparison of the kinetic parameters of KpALS and KpAHAS 
KpAHAS was found to be a much slower enzyme, with a kcat value almost 60-fold lower 
than that measured for KpALS. On the other hand, the Km value for pyruvate in KpAHAS was also 
lower, with Km values, on average, at least 2-3-fold lower than those obtained for KpALS. For a 
direct comparison, both enzymes were assayed in MOPS at pH 7.0 with the addition of 50 mM 
acetate. The addition of acetate was required for ALS activity under these conditions. As with 
assays performed in phosphate at pH 8.0 in the presence of acetate, KpAHAS showed only a 2-
fold decrease in kcat value with no observed effect on Km. 
Interestingly, under these conditions KpALS and KpAHAS were shown to have similar 
values for Km. The Km value of KpALS for pyruvate was found to the the lowest measured in all 
conditions at ~6 mM, which is similar to the ~4 mM value obtained for KpAHAS. However, 
despite the similarity in Km values, the values for kcat remained significantly different. 
Notwithstanding KpALS showing an almost 4-fold decrease in kcat in MOPS, that value was still 
~40-fold higher than the value obtained for KpAHAS (Table 3.5). 
Table 3.5: Steady-state parameters for KpALS and KpAHAS in MOPS buffer at pH 7.0. 
 kcat (s-1) Km (mM) kcat/Km (mM-1s-1) 
KpALS 120 ± 5 6 ± 1 20 
KpAHAS 3.3 ± 0.2 4.0 ± 0.8 0.8 
 
3.2.6 Inhibition by β-fluoropyruvate 
β-fluoropyruvate (β-FP), a pyruvate analogue, has been shown to be an inhibitor of 
pyruvate-utilizing ThDP-dependent enzymes (32,33). Typically, it blocks the active site by acting 
as a slow alternative substrate where it is converted to acetate following the loss of a fluoride ion. 
The mechanism of inhibition is discussed in detail in Chapter 4.  
Initial-rate data were fit to the equations for competitive, uncompetitive, noncompetitive, 
and mixed inhibition using the enzyme kinetics package in Sigmaplot 12 (Systat Software). For 
KpALS, the pattern of inhibition was found to be mixed with Ki and Ki′ values of 40 and 92 μM, 
respectively. A similar, but not identical, pattern of inhibition was observed for KpAHAS 
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(Figure 3.4). On balance, the inhibition of KpAHAS by β-fluoropyruvate was deemed to be 
noncompetitive with a Ki of 100 μM. However, the errors involved in the calculation were such 
that mixed inhibition was not out of the question.  
 
 
Figure 3. 4: Michaelis-Menten and Lineweaver-Burk plots of A) KpALS and B) KpAHAS 
inhibition by micromolar concentrations of β-fluoropyruvate 
 
The patterns of inhibition observed for these enzymes were not unexpected as they can use 
two identical substrates, of which β-fluoropyruvate is an analogue. The mixed inhibition observed 
for KpALS indicates that the inhibitor binds to both the unreacted enzyme, mimicking the donor 
substrate, and to the E-S complex, mimicking the acceptor substrate. However, the effect appears 
to be slightly stronger toward the unreacted enzyme than to the E-S complex, potentially indicating 
that the inhibitor competes more strongly with the donor substrate than the acceptor. The 
noncompetitive inhibition observed for KpAHAS indicates that the inhibitor binds to both sites 
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equally, i.e., it competes equally with both the donor and acceptor substrates. Interestingly, for 
both enzymes, the Ki for β-fluoropyruvate was found to be at least an order of magnitude lower 
than the Km values calculated for pyruvate. 
3.2.7 Use of α-ketobutyrate as an alternative substrate in KpALS and KpAHAS 
One possible product of ALS and AHAS enzymes that is rarely considered is the 
condensation of two molecules of α-ketobutyrate (αKB) to form propiohydroxybutyrate (Figure 
3.1). The lack of interest in this activity is likely due to the fact that it appears 
propiohydroxybutyrate has no known biological significance. Regardless, the ability of both 
enzymes to catalyze this reaction was investigated.  
For KpALS, very little ability to form propiohydroxybutyrate was observed. In fact, 
evidence for formation of a chiral product was only observed after the reaction was allowed to 
proceed for 16 hours, and even then only a small amount was formed (Figure 3.5, A). This 
represented less than 10% of the signal observed when the enzyme forms (S)-acetolactate from the 
same concentration (25 mM) of pyruvate (Figure 3.5, B).  
Conversely, KpAHAS was shown to readily form this product with a kcat value of 2.4 ± 0.1 
s-1 and Km value of 14 ± 1 mM. This represents only a 10-fold decrease in catalytic efficiency for 
the formation of propiohydroxybutyrate compared to that for acetolactate formation. Given this, it 
would appear that KpAHAS is able to use the larger substrate not only as an acceptor, but also as 
a donor.  
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Figure 3.5: CD scan overlays of A) KpALS reacted with 25 mM α-ketobutyrate after 5 minutes 
(blue) and 16 hours (green), and B) overlay of A with CD scan of reaction of KpALS with 25 
mM pyruvate after 5 minutes (red). 
 
Figure 3.5 shows that KpALS is not able to form a chiral product from two molecules of 
α-ketobutyrate in any significant amount, even after long incubation periods. However, this does 
not rule out the possibility that the enzyme can form acetohydroxybutyrate, simply that it cannot 
form significant amounts of propiohydroxybutyrate.  
To gain insight on the lack of carboligation activity, experiments were performed to 
determine if KpALS could decarboxylate α-ketobutyrate. In this scenario, the reaction would see 
the conversion of αKB to propionaldehyde. If decarboxylation is observed, it would confirm that 
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the substrate can bind in the active site as a donor substrate positioned for attack by ThDP. This 
was certainly not an unreasonable experiment, particularly as BsALS was shown to be a fairly 
effective decarboxylase of α-ketoisovalerate, a similar substrate (13). Using the coupled 
decarboxylase assay (section 2.4.3), no evidence was observed for decarboxylation of 
α-ketobutyrate. Unfortunately, these results are not conclusive as similar results were obtained 
when the same experiment was performed to test for KpALS-catalyzed decarboxylation of 
pyruvate, a compound known to bind as a donor substrate.  
3.3 Product distribution analysis of KpALS and KpAHAS 
3.3.1 Establishment of method for simultaneous product analysis 
To determine whether KpALS and KpAHAS prefer to form acetolactate or 
acetohydroxybutyrate, the products must be analyzed simultaneously. To do this, a modified form 
of the gas chromatography based method reported by Gollop et al. (24) was designed and 
implemented. The procedure for this analysis, described in detail in Chapter 2, was carried out in 
four basic steps:  
1) Enzymatic reactions were performed in the presence of both pyruvate and 
α-ketobutyrate under steady-state conditions. 
2) The acetohydroxyacid products were then heated in the presence of catalytic amounts 
of iron (II) sulfate and iron (III) chloride to form diketones in an oxidative 
decarboxylation reaction. 
3) The volatile diketones were then extracted from the aqueous reaction mixture and 
captured in methanol using an air distillation apparatus (Figure 3.6). 
4) The methanol solution containing the diketone analytes was then injected into a GC-
MS equipped with a VF-23 column for separation and analysis.  
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Figure 3.6: Air distillation apparatus. Metered air (~100 mL/min) from the flow valves 
[1] is passed through the aqueous sample in the large side-arm test tubes [2] held at 60 °C. The 
air, now containing the volatile diketones, then continues to the collection tubes [3] containing 
ice-cold methanol. 
 
 
The first step in establishing the method was to optimize the separation of the diketones by 
GC. A standard solution was prepared containing 2,3-butanedione, 2,3-pentanedione, 3,4-
hexanedione, and acetoin in methanol. 3,4-Hexanedione was added to the standards as it is the 
diketone product following oxidative decarboxylation of propiohydroxybutyrate (Figure 3.1), and 
also to ensure it was resolved from the other compounds so any formation would not interfere with 
peak identification and integration. Finally, acetoin was included as an internal standard.  
Using this standard solution, injection volume, split ratio, and column oven temperatures 
were optimized to provide excellent separation in a short time frame. Mass spectrometric detection 
was used to identify and quantify compounds as they were eluted. Overall, an efficient separation 
was achieved with a total run time of 5.4 minutes. Retention times for 2,3-butanedione, 2,3-
pentanedione, 3,4-hexanedione, and acetoin were found to be 2.7 minutes, 3.4 minutes, 4.0 
minutes, and 4.8 minutes, respectively (Figure 3.7).  
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Figure 3.7: Chromatogram of GC separation. Elution order: 1) 2,3-butanedione, 
2) 2,3-pentanedione, 3) 3,4-hexanedione, and 4) acetoin. 
 
 
Following optimization of the procedure, standards were prepared to contain 250 μM, 500 
μM, 750 μM, and 1000 μM of each 2,3-butanedione and 2,3-pentanedione in methanol. Acetoin 
was also added to each standard to a final concentration of 1000 μM. The standards were analyzed, 
and the resulting peaks were integrated. Normalized peak areas were used to create calibration 
curves for the diketone analytes (Figure 3.8).  
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Figure 3.8: Calibration curves for 2,3-butanedione and 2,3-pentanedione. 
 
Normalization was achieved by division of integrated peak areas corresponding to 
butanedione and pentanedione by the peak area of acetoin. This served to correct for errors in 
injection volume as well as for errors in methanol capture volume introduced by pipetting errors 
or evaporation during the extraction step. Signal response was found to be linear over the range 
tested, and the sensitivity for both butanedione and pentanedione was found to be effectively 
identical. 
Following construction of the calibration curves, the efficiency of the air exchange step 
was determined. This was achieved by performing the air distillation step on aqueous diketone 
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standards and then analyzing the extracted samples. Extraction of diketone analytes was found to 
be fairly linear over the range tested (Figure 3.9), and the extraction efficiency was found to be the 
almost identical for both 2,3-butanedione and 2,3-pentanedione at ~80 ± 5%. 
 
 
Figure 3.9: Fit of extraction normalized peak areas following extraction. A) shows the 
concentration calculated after each extraction plotted against the concentration of the standards 
before extraction. B) shows the extraction efficiency of each standard. Lines are drawn at a 
constant extraction efficiency of 80%. 
3.3.2 Specificity ratio of KpAHAS 
 The specificity ratio of ALS and AHAS enzymes is a measure of the preference for 
using either pyruvate or α-ketobutyrate as the acceptor substrate. As defined, a value greater than 
1 represents a preference for α-ketobutyrate, while a value less than 1 represents a preference for 
pyruvate. The ratio (R, Equation 3.1) was defined by Gollop et al. (25) as the ratio of the rates 
formation of acetohydroxybutyrate (AHB) to acetolactate (AL) divided by the ratio of the initial 
concentrations of α-ketobutyrate (αKB) to pyruvate (Pyr). 
Equation 3.1:  𝑅 =
𝑉𝐴𝐻𝐵 𝑉𝐴𝐿⁄
[𝛼𝐾𝐵] [𝑃𝑦𝑟]⁄
 
74 
 
To examine the acceptor preference in KpAHAS, reactions were performed under initial 
rate conditions in 100 mM phosphate buffer at pH 8.0 in the presence of both pyruvate and 
α-ketobutyrate. Pyruvate concentration was held constant at 10 mM while the concentration of 
α-ketobutyrate was varied from 100 μM to 1000 μM. Each reaction was run for 5 minutes before 
quenching with phosphoric acid.  
Following extraction, GC-MS chromatograms were obtained for each sample. Each 
chromatogram contained three peaks. By comparison of the retention times with the standards and 
inspection of the fragmentation data from the mass spectrometer, the peaks were identified as 2,3-
butanedione, 2,3-pentanedione, and acetoin, as expected (Figure 3.10). It was immediately 
noticeable that the peak corresponding to 2,3-pentanedione was much larger than that for 2,3-
butanedione. This indicated that KpAHAS formed much more acetohydroxybutyrate than 
acetolactate. Interestingly, no evidence of 3,4-hexanedione was obtained in any of the reactions, 
regardless of the concentration of α-ketobutyrate.  
 
 
Figure 3.10: Typical chromatogram obtained following diketone extraction from reactions 
catalyzed by KpAHAS. Labeled peaks: 1) 2,3-butanedione, 2) 2,3-pentanedione, and 3) acetoin. 
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When the ratios of the rates of product formation are plotted against the ratio of the initial 
substrate concentrations, the slope of the linear fit is the specificity ratio (Figure 3.11). The 
specificity ratio was found to be close to 70, indicating that KpAHAS, as with most AHASs studied 
to date (26), shows a strong preference for α-ketobutyrate as the acceptor substrate.  
 
 
Figure 3.11: Fit of product ratios to determine the specificity ratio for KpAHAS. 
 
The ability to separate the formation of acetohydroxybutyrate and acetolactate makes it 
possible to calculate the steady-state parameters for the formation of acetohydroxybutyrate. Fitting 
of the initial rate data showed that formation of acetohydroxybutyrate followed Michaelis-Menten 
kinetics (Figure 3.12).  
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Figure 3.12: Michaelis-Menten plot for formation of acetohydroxybutyrate by KpAHAS. 
Table 3.6: Kinetic parameters for formation of varied products in KpAHAS in phosphate buffer 
at pH 8.0. The assay method is in parenthesis. 
Product kcat (s-1) Km (mM)  kcat/Km (mM-1s-1) 
Acetolactate (CD) 7.5 ± 0.4 3.8 ± 0.4  2 
Acetohydroxybutyrate (GC-MS) 5.8 ± 0.3 0.37 ± 0.05  16 
Propiohydroxybutyrate (CD) 2.4 ± 0.1 14 ± 1  0.2 
  
The value obtained for kcat was found to be similar, though slightly lower than, the kcat 
obtained from monitoring acetolactate formation via CD (Table 3.6). The slightly lower value of 
kcat is not unexpected as the higher kcat obtained for acetolactate formation was obtained with only 
pyruvate present in the reaction mixture. The slow formation of acetolactate likely contributes, at 
least in part, to the slightly reduced kcat value. Even at semi-saturating conditions of α-ketobutyrate, 
there was still some measurable formation of acetolactate. 
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As both AHAS and ALS are able to condense two identical molecules to form product, it 
is difficult to decipher whether the Km value calculated when monitoring acetolactate or 
propiohydroxybutyrate is for that of the donor or acceptor site. However, Km values for 
α-ketobutyrate as both a donor and acceptor can be estimated by comparison with the data obtained 
from GC-MS analysis.  
The Km value for α-ketobutyrate obtained by monitoring acetohydroxybutyrate formation 
was determined to be 0.37 mM. This is at least 10-fold lower than that calculated by following 
either acetolactate or propiohydroxybutyrate formation. As acetohydroxybutyrate is formed when 
the enzyme uses pyruvate as the donor and α-ketobutyrate as the acceptor, the Km value obtained 
for α-ketobutyrate must be for it acting as an acceptor.  
Given that the Km value obtained from monitoring formation of propiohydroxybutyrate by 
CD in is ~40-fold higher than that for acetohydroxybutyrate formation, the Km value for formation 
of propiohydroxybutyrate must be for α-ketobutyrate acting as the donor substrate. 
While this analysis is quite reasonable, there is one caveat that must be considered: the 
assumption that the binding of the donor substrate, whether it is pyruvate or α-ketobutyrate, does 
not significantly impact the ability of either substrate to act as an acceptor. If it were to be shown 
that binding of one substrate over another as a donor influenced binding of the acceptor, then the 
analysis would need to be revisited. However, inspection of the active site in a KpAHAS homology 
model shows that it is possible for α-ketobutyrate to bind without any major arrangement of active 
site architecture (Figure 3.13).  
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Figure 3.13: Active site of KpAHAS with A) pyruvate as a donor substrate, and B) 
α-ketobutyrate as a donor substrate. Van der Waals radii for the spheres were calculated using 
standard options in UCSF Chimera based on radii reported by Tsai et al. (34). 
 
 
A model of KpAHAS was generated using the Phyre2 web portal (35) with AHAS from 
yeast (PDB ID: 1T9B) as a template. This model was then aligned with a crystal structure of 
KpALS that contained a trapped ALThDP intermediate. Using the model building tool it was 
possible to add an extra methyl group to mimic the space required for binding of α-ketobutyrate 
as a donor substrate. All structure alignments, manipulations, and visualizations were performed 
using UCSF Chimera (36). Some slight clashing is observed with Val375, though it is independent 
of whether the donor is pyruvate or α-ketobutyrate. Likely this is due to the model being generated 
in the absence of the ALThDP intermediate. 
3.3.3 Specificity ratio of KpALS 
The specificity ratio of KpALS was also investigated. Reactions were carried out under 
initial rate conditions using a mixture of 10 mM pyruvate in the presence of 10, 15, 20, and 25 mM 
α-ketobutyrate. After 5 minutes, the reactions were quenched, products were converted into 
diketones, and the diketones were extracted to methanol before injection into the GC-MS.  
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The resulting chromatograms (Figure 3.14) showed that the specificity of KpALS was the 
opposite of that observed for KpAHAS in that KpALS formed more acetolactate than 
acetohydroxybutyrate. Reaction rates were calculated from the normalized peak areas and the data 
were fit to equation 3.1 to determine the specificity ratio (Figure 3.15). The ratio was found to be 
0.08 indicating that KpALS shows a ~10-fold preference for pyruvate as an acceptor substrate. 
 
 
Figure 3.14: Typical chromatogram obtained following diketone extraction from reactions 
catalyzed by KpALS. Labeled peaks: 1) 2,3-butanedione, 2) 2,3-pentanedione, and 3) acetoin. 
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Figure 3.15: Fit of product ratios to determine the specificity ratio for KpALS. 
That being said, while the specificity ratio calculated for KpALS shows a 10-fold 
preference for pyruvate as an acceptor, the amount of acetohydroxybutyrate formed in the 
reactions was not insignificant. This is particularly significant as more acetohydroxybutyrate was 
formed in the five-minute reactions than propiohydroxybutyrate when α-ketobutyrate was used as 
a sole substrate over 16 hours. Overall, this indicates that KpALS is more specific for pyruvate as 
a donor than it is for pyruvate as an acceptor. 
A possible explanation for the lack of propiohydroxybutyrate formation is found by 
comparing the active site of KpALS with that of the KpAHAS homology model. In the former, 
Gln420 occupies the position of Gly401 in the AHAS model. When α-ketobutyrate rather than 
pyruvate is used as the donor, Gln420 shows strong steric clashes with the extra methyl group. 
This provides a plausible rationale as to why KpALS is not able to form any significant amount of 
propiohydroxybutyrate, i.e., α-ketobutyrate simply cannot fit in the donor site without significant 
rearrangement of the active site residues (Figure 3.16). 
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Figure 3.16: Depiction of clash of Gln420 (pink) with α-ketobutyrate 
(blue) as a donor substrate. 
3.4 Summary and conclusions 
The work presented in this chapter describes the comparison of the properties of two 
enzymes, ALS and AHAS, from the same organism that catalyze the same carboligation reaction. 
The products of that reaction, (S)-acetolactate and (S)-acetohydroxybutyrate are formed by the 
condensation of two molecules of pyruvate, or one molecule of pyruvate and one molecule of 
α-ketobutyrate, respectively. The steady-state kinetics of the two enzymes were studied using three 
different methods: i) the Westerfeld method (21), ii) the CD method (28), and iii) product 
conversion to diketones and separation by GC-MS (24). The first two methods were non-specific 
for acetolactate and acetohydroxybutyrate, while the third method allowed for separation and 
analysis when the two products are formed simultaneously. 
Steady-state analysis monitoring the formation of acetolactate showed that the kinetic 
parameters of KpALS were buffer dependent with activation by acetate and inhibition by 
phosphate being observed. Additionally, the enzyme showed Michaelis-Menten kinetics in acetate 
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and MES buffers while sigmoidal kinetics were observed in phosphate. This buffer dependence 
was not observed for KpAHAS. 
Both enzymes were shown to be susceptible to inhibition by β-fluoropyruvate, a pyruvate 
analogue, and the mode of inhibition was found to be similar for both enzymes. β-fluoropyruvate 
showed a mixed type inhibition for KpALS, and the Ki values obtained indicated that the inhibitor 
binds more tightly in the donor site than the acceptor site. Noncompetitive inhibition was observed 
for KpAHAS with a Ki value slightly higher than that for inhibition of KpALS. The noncompetitive 
nature of the inhibition indicates that the compound binds equally to both the donor and acceptor 
sites. 
Finally, the substrate specificities of KpALS and KpAHAS were investigated. Initially, the 
enzymes were tested for their ability to condense two molecules of α-ketobutyrate to form 
propiohydroxybutyrate. KpAHAS was shown to be able to form significant amounts of 
propiohydroxybutyrate, although the efficiency of this conversion was lower than that for 
acetolactate formation. Conversely, KpALS was only able to form miniscule amounts of this 
product, even after incubation for 16 hours. 
KpAHAS was found to form more acetohydroxybutyrate than acetolactate in a given 
reaction even when the pyruvate concentration was almost 100-fold higher than the α-ketobutyrate 
concentration. An explanation for this observation came when it was determined that KpAHAS 
has a ~70-fold preference for α-ketobutyrate as the acceptor substrate. 
Highlighting the difference between the enzymes, KpALS showed the opposite pattern 
with a ~10-fold preference for pyruvate as the acceptor substrate. On the surface this may not seem 
to be a particularly strong preference until it is realized that the cellular concentration of pyruvate 
is ~100-fold higher than that of α-ketobutyrate (25,37,38). Given those levels, it is apparent that 
KpALS is not likely to catalyze the formation of any significant amount of acetohydroxybutyrate 
in vivo.  
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CHAPTER 4.  STRUCTURAL STUDIES ON ACETOLACTATE 
SYNTHASE FROM KLEBSIELLA PNEUMONIAE 
4.1 Introduction 
The biosynthesis of 2,3-butanediol from pyruvate in facultative anaerobes is carried out by 
a cascade of enzymes including acetolactate synthase, acetolactate dehydrogenase, and butanediol 
dehydrogenase (1). This pathway is of great interest for commercial synthesis projects as 2,3-
butanediol is used as a building block in the synthesis of antifreeze agents, extractants, solvents, 
and biofuels (2). The first enzyme in this pathway, acetolactate synthase (ALS), is of particular 
interest as acetolactate is readily decarboxylated into either 2,3-butanedione or acetoin, both of 
which are important aroma compounds in products such as butter and buttermilk (3). Surprisingly, 
few acetolactate synthase enzymes have been studied throughout the years. The few that have 
include those from Aerobacter aerogenes (4-6), Enterobacter cloacae (7), Bacillus subtilis (2,8), 
and Klebsiella pneumoniae (9). Only two of these enzymes, those from B. subtilis and K. 
pneumoniae, have been studied using X-ray crystallography. Despite their similarity in function, 
the two enzymes were shown to cluster in different phylogenetic groups (8), and the structural 
studies showed many distinctions between them. Given these differences it appears that there is 
still much to learn about the correlation between structure and function of the ALS family of 
enzymes. 
4.1.1 Structural studies on ALS enzymes 
It is notable that the protein data bank contains many structures of acetohydroxyacid 
synthase (AHAS). These arise from a diverse set of organisms including plants (Arabidopsis 
thaliana (10-13)), fungi (Saccharomyces cerevisiae (12-16) and Candida albicans (17)), and 
bacteria (E. coli (18,19)). By contrast, ALS is quite rare in plants and fungi, so it is not surprising 
that the structures that have been solved are those of bacterial enzymes.  
In spite of the paucity of structures, several of those that are available are of ALS in 
complex with trapped reaction intermediates. In the B. subtilis (BsALS) structure, a trapped 
lactylThDP (LThDP) intermediate was observed, while a hydroxyethylThDP (HEThDP) 
intermediate was observed in the K. pneumoniae (KpALS) structures (8,9).  
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When considering the accepted reaction mechanism of ALS, discussed in Chapter 1 
(Figure 1.14), the observation of LThDP in BsALS is not unexpected as it is the intermediate 
formed following attack by the ThDP ylid on the first (donor) pyruvate substrate. Further, 
accumulation of enough of this intermediate to be observed in a X-ray structure indicates that the 
rate-limiting step in the reaction may be decarboxylation. That said, while this may be true in the 
crystal, this doesn’t necessarily indicate that it is the rate-limiting step for BsALS in solution.  
The HEThDP intermediate observed in KpALS is particularly interesting. This 
intermediate was somewhat unexpected, as it would more likely to be observed in a simple 
decarboxylation reaction since its observation requires the carbanion/enamine intermediate to be 
protonated instead of attacking a second (acceptor) substrate (Figure 4.1). This protonation is more 
akin to the reaction catalyzed by pyruvate decarboxylase, which yields acetaldehyde (20), than the 
carboligation reaction catalyzed by ALS, which yields acetolactate.  
In order to observe these intermediates, crystals of the BsALS and KpALS were soaked 
with pyruvate. The unexpected observation of an apparent off-pathway HEThDP intermediate in 
KpALS, rather than the on-pathway LThDP intermediate in BsALS, is likely explained by design 
of the soaking experiments. KpALS crystals were soaked in pyruvate for a week, whereas the 
BsALS crystals were soaked for only 3 seconds before being flash frozen. Given these 
experimental differences, the observation of different intermediates seems quite reasonable. 
Presumably, the substrate concentration remained high in the BsALS crystals due to the short 
soaking period, while the long soaking period for KpALS allowed for significant depletion of 
pyruvate from the soaking solution. 
As the decarboxylation step is irreversible, it is likely that any equilibrium established 
between pyruvate and acetolactate would lie heavily toward the formation of acetolactate. 
However, this does not preclude the possibility of back reaction of acetolactate to any of the post-
decarboxylation steps. Such reaction could see the breakdown of acetolactate to one molecule of 
pyruvate concomitantly with the formation the carbanion/enamine intermediate. Of course most 
of this will be immediately converted back into acetolactate but, if even a small amount of pyruvate 
escaped the active site, the reactive carbanion/enamine could be protonated, potentially leading to 
the formation and release of acetaldehyde. While experiments described in section 3.2.7 indicate 
that decarboxylation is not observed on the time scale of a routine assay, over the period of a week, 
the “occasional” decarboxylation reaction could be repeated many times. Ultimately, pyruvate 
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would be depleted from the soaking solution and an equilibrium would be established between 
acetolactate and acetaldehyde. At this point, the equilibrium binding of acetaldehyde to the ThDP 
cofactor is now much more feasible and the observation of the HEThDP intermediate is not so 
unlikely.  
 
 
Figure 4.1: Reaction mechanisms of A) acetolactate and B) acetaldehyde formation by ThDP-
dependent enzymes. 
 
Another key difference was observed between the trapped intermediates in BsALS and 
KpALS. The trapped intermediate found in KpALS was found to adopt an unusual tricyclic 
dihydrothiachrome diphosphate form of ThDP (Figure 4.2). At the time this form of ThDP had 
never before even been crystallized in solution, much less bound to an enzyme  (9). Conversely, 
no evidence for this form of ThDP was observed in BsALS. In fact, the tricyclic form of ThDP has 
only been seen in one other enzyme to date, a phosphoketolase variant from Bifidobacterium breve 
(21). 
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Figure 4.2: Forms of ThDP found in X-ray structures of KpALS. A) Thiazolium form 
(PDB ID: 5DX6), and B) dihydrothiachrome form with trapped HEThDP intermediate 
(PDB ID: 1OZH). 
 
Observation of the dihydrothiachrome form of ThDP immediately led to speculation on its 
importance in the reaction mechanism of KpALS. Pang et al. (9) proposed a mechanism in which 
the tricyclic form is formed and broken throughout the catalytic cycle. The mechanism involved 
the initial formation of a less stable resonance form of ThDP in which a charge migration occurs 
from the nitrogen atom (N+ form) to the sulfur atom (S+ form) in the thiazolium ring (9). 
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Figure 4.3: A) N+ and B) S+ forms of ThDP. 
 
While the S+ form initially seems like an unlikely resonance form to exist in significant 
amounts, it has been proposed before in studies of the ThDP cofactor itself. In fact, calculations 
performed on the crystal structure of ThDP indicated that the N+ form was only favored over the 
S+ form by a factor of ~2:1 (22,23). This would suggest that the latter form exists in significant 
amounts, at least in crystalline ThDP, providing some support for the proposed mechanism.  
A recent computational study looking at the reaction mechanism of benzoylformate 
decarboxylase (BFDC), suggested that KpALS is not unique in the formation of the tricyclic form 
of ThDP (24). The authors postulated that the tricyclic intermediates act as kinetic traps. Although 
they were found to be more stable than their equivalent thiazolium-type intermediate they have no 
path to move forward in the reaction cycle, indicating that they are unproductive off-pathway 
intermediates (24). 
In an attempt to (i) determine the importance of soak time on the observation of ALS 
intermediates and (ii) obtain additional information about the tricyclic intermediates of ThDP, a 
series of soaking experiments was carried out. 
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4.2 X-ray Crystallography of KpALS 
KpALS was crystallized using crystallization conditions described in section 2.7.1, and 
crystals appeared in drops within 5-7 days at 4 °C (Figure 4.4). 
 
 
Figure 4.4: Typical KpALS crystal used for soaking experiments. 
 
In total, these crystals were soaked separately with three compounds (Figure 4.5), pyruvate, 
phosphonodifluoropyruvate, and β-fluoropyruvate, before diffraction data was collected. These 
compounds were chosen as it was thought that each might highlight different properties of the 
enzyme. The first compound, pyruvate, was chosen in hopes that a reaction intermediate could be 
trapped following a quick soaking experiment. The second compound, 
phosphonodifluoropyruvate (PnDFP), was chosen in an attempt to provide structural evidence for 
its proposed mechanism of inhibition of phosphonopyruvate decarboxylase, another ThDP-
dependent enzyme (25). Finally, the third compound, β-fluoropyruvate, is a known inhibitor of 
other pyruvate-utilizing enzymes such as the E1 subunit of the pyruvate dehydrogenase complex 
(26), and was chosen in an attempt to observe an enzyme-inhibitor complex. Ultimately, these 
soaking experiments resulted in observation of many unique features of the enzyme that are 
discussed in this chapter. 
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Figure 4.5: Chemical structures of compounds used for ligand soaking 
experiments. A) Pyruvate, B) PnDFP, and C) β-fluoropyruvate. 
4.2.1 General structural features 
In all cases, crystals of KpALS were found to belong to monoclinic spacegroup I121 with 
unit cell dimensions a = 85, b = 134, and c = 111 Å. The structures were solved by molecular 
replacement using a search model consisting of a single monomer from a previously published 
structure of KpALS (PDB ID: 1OZF) with water molecules and ligands removed. The asymmetric 
unit was found to consist of two monomers of KpALS in a non-biologically active dimer. In 
agreement with previously published structures, analysis by PISA (27) showed that, like many 
other members of the ThDP-dependent decarboxylase family, including benzoylformate 
decarboxylase from Pseudomonas putida (28), and pyruvate decarboxylase from Zymomonas 
mobilis (29), the biological assembly of KpALS is a tetramer. Often the tetrameric assembly 
formed by enzymes in this family is better described as a “dimer of dimers” (Figure 4.6). 
Additionally, with the exceptions discussed below, each monomer was found to contain at least 1 
magnesium ion, 1 molecule of ThDP (or a trapped ThDP complex), and 1 phosphate ion in addition 
to the protein chain. A summary of crystallographic data, model, and refinement statistics for all 
data sets is presented in Table 4.1. 
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Figure 4.6: Tetrameric structure of KpALS. The asymmetric unit is 
represented by monomers A and D, while the functional dimers are 
represented by monomers A and B and monomers C and D. 
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Table 4.1: Data, model, and refinement statistics for KpALS X-ray crystal structures 
Data Set Pyruvate β-fluoropyruvate PnDFP 
PDB ID 5WDG 5DX6 5D6R 
Space group I121 I121 I121 
Unit cell Dimensions    
a, b, c (Å) 85.47, 134.41, 110.75 84.8, 134.01, 110.77 85.12, 133.35, 110.62 
α, β, γ (°) 90.0, 95.5, 90.0 90.0, 95.5, 90.0 90.0, 95.4, 90.0 
Resolution range (Å)a 55.12–2.12 (2.19–2.12) 42.57–1.75 (1.81–1.75) 46.28–2.28 (2.36–2.28) 
No. reflections 238251 440033 196557 
No. unique reflections 70787 124191 56232 
Completeness (%)a 99.9 (99.7) 99.9 (99.5) 100.0 (99.8) 
Multiplicitya 3.4 (3.3) 3.5 (3.4) 3.5 (3.4) 
Linear Rmerge, (%)b 10.8 (94.2) 6.6 (82.5) 9.1 (78.2) 
Mean I/ (I)a 6.58 (1.75) 9.29 (1.50) 8.57 (1.44) 
Refinement statistics    
cRwork 0.203 0.151 0.208 
dRfree 0.246 0.189 0.237 
No. of atoms 8653 9100 8538 
Protein 8059 8248 8188 
Ligands 98 72 83 
Water 496 780 267 
B-factors (Å2)    
Average B-factor 46.27 35.33 54.01 
Protein 46.38 34.81 54.33 
Ligands 54.44 34.83 55.31 
RMSDe (bonds, Å) 0.002 0.008 0.003 
RMSDe (angles, °) 0.49 0.81 0.74 
Clashscore 5.91 3.57 1.41 
aValues in parentheses refer to statistics in the highest-resolution shell. 
bLinear Rmerge = Σ|Iobs – Iavg|/ΣIavg 
cRwork = Σ|Fobs – Fcalc|/ΣFobs 
dRfree was calculated as Rwork where ~3.5–5% of the reflection data was selected at random as a test 
set and excluded from refinement.  
eRMSD – root mean square deviation.  
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4.2.2 Crystals soaked with pyruvate 
The initial experiment was performed by soaking crystals in 100 mM pyruvate for 5 
seconds as described in Chapter 2. Theses crystals diffracted to a resolution of 2.1 Å and the 
structure was refined to a final Rwork/Rfree of 0.203/0.246 using the approach outlined in section 
2.7.4. Upon molecular replacement and subsequent placing of the ThDP cofactor, extra electron 
density was observed stemming from C2 on the ThDP cofactor, suggestive of a potential reaction 
intermediate. Originally, it was thought that this density could correspond to an intermediate 
similar to that observed in BsALS, i.e. the LThDP intermediate (8). However, all refinement with 
LThDP resulted in significant extra positive difference density near the carboxylate group. This 
led to the idea that the trapped intermediate may be of the last step of the reaction immediately 
before product release, the acetolactylThDP (ALThDP) intermediate, as the bulkier intermediate 
could potentially fit the extra density. Concomitantly, there appeared extra positive difference 
density between C2 and the 4′ amino group on the pyrimidine ring suggesting that the cofactor 
may be in the tricyclic form previously observed in KpALS. Indeed, upon refinement with the 
tricyclic ALThDP intermediate, the resulting electron density was observed to fit this intermediate 
quite well (Figure 4.7).  
Observation of this tricyclic intermediate supports the conclusions of the computational 
study on BFDC (24). The tricyclic forms proposed for BFDC correspond to two intermediates in 
the mechanism of ALS: i) unreacted ThDP, and ii) the ALThDP intermediate. Given that tricyclic 
HEThDP had already been seen in KpALS, the observation of tricyclic ALThDP is not entirely 
surprising. In fact, it is likely that the stability the tricyclic form is a key factor that allowed for 
sufficient accumulation of the intermediate to be observed in an X-ray crystal structure.  
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Figure 4.7: A) Chemical structure and B) electron density fit (1 σ) of the 
tricyclic ALThDP reaction intermediate. 
 
Given the observation of the tricyclic ALThDP species in the crystal structure, and how 
well it correlates with evidence provided by the computational studies on BFDC, the proposed 
mechanism of acetolactate formation should be updated to include the tricyclic intermediate. As 
such, an updated mechanism can be seen in Figure 4.8.  
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Figure 4.8: Updated mechanism for the formation of (S)-acetolactate by KpALS. 
 
The acetolactyl moiety in ALThDP was observed to be held in place by hydrogen bond 
interactions with several water molecules held in place by side chain and backbone interactions 
with Ala35, Lys6, Thr80, Ser81, Gln120, and Gln420 (Figure 4.9). 
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Figure 4.9: Hydrogen bonding interactions (≤ 3.2 Å) of acetolactyl moiety of ALThDP with 
protein chain and water molecules in the active site. 
 
The acceptor pyruvate is found in a similar position to that suggested by Pang et al. in 
which the acceptor pyruvate molecule approaches the enamine/carbanion intermediate from above 
and is clearly in position to form (S)-acetolactate (Figure 4.10). The model agrees with the 
observed ALThDP quite well including the prediction of hydrogen bond interactions with Ala35, 
Lys36, and Gln420 (9).  
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Figure 4.10: Predicted model of second substrate binding in the 
active site of KpALS. Reproduced from Pang et al. (9). 
 
That said, the proposed model differs from the observed intermediate in a few ways. First, 
and not unreasonably, the model did not consider water molecules in the active site. Clearly, they 
are a key feature in the stabilization of the carboxylate group in ALThDP observed here. Second, 
while the location of the acceptor pyruvate is similar, its orientation differs between the predicted 
model and the observed intermediate. In the latter, the carboxylate group of the acceptor points 
toward the backbone nitrogen atoms of Ala35 and Lys36, while it was predicted to point toward 
Gln420 in the model. In fact, the model predicted an interaction between the backbone nitrogen of 
Ala35 and the carbonyl oxygen of pyruvate. This interaction was proposed to be one of the 
interactions explaining the formation of solely (S)- rather than (R)-acetolactate. In ALThDP 
however, no such interaction is observed, and the oxygen atom was found to be involved in very 
few, if any, interactions with active site residues.  
Finally, Gln483 was proposed to be involved with coordination of the carboxylate group. 
This residue is found on a loop folded over the top of the active site. This residue has since been 
observed to take on multiple conformations depending on presence of reaction intermediates in the 
active site. In the presence of ALThDP Gln483 was observed to be folded away from the active 
site, likely to prevent steric clash with the acceptor substrate. However, as seen in Figure 4.9, it 
reaches down into the active site when either no, or smaller, reaction intermediates are in the site.  
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Looking at the binding mode and conformation of ALThDP, the positioning of the acceptor 
in the active site appears to be controlled by hydrophobic interactions as much as by hydrogen 
bonding. The methyl groups found in the acetolactyl moiety are in close proximity with residues 
Met394 and Met479 (Figure 4.11). Due to the proximity of these residues to the acetolactyl moiety, 
they likely contribute to substrate orientation in the active site, and, by extension, the 
stereospecificty of the enzyme. 
 
 
Figure 4.11: Interaction of the methyl groups of ALThDP (tan) and side-chains of Met394 and 
Met479 (green) shown as spheres. 
4.2.3 Crystals soaked with phosphonodifluoropyruvate (PnDFP) 
In a second experiment, crystals of KpALS were soaked in PnDFP for two weeks before 
being flash frozen in liquid nitrogen. These crystals diffracted to 2.28 Å, and the model was refined 
to a final Rwork/Rfree of 0.208/0.237 using the approach outlined in section 2.7.4. As with the 
crystals soaked with pyruvate, upon molecular replacement and subsequent placing of the ThDP 
cofactor, extra electron density was observed stemming from C2 of the ThDP cofactor.  
PnDFP was originally synthesized (25) as a mechanism-based inhibitor of 
phosphonopyruvate decarboxylase (PnPyrDC). However, as PnPyrDC is refractory to 
crystallization, no structural evidence of the inhibitor complex has previously been obtained. 
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KpALS is more easily crystallized, acts on a similar substrate, and has a relatively large binding 
pocket. Consequently, it was thought that ALS could act as a surrogate for PnPyrDC to gain 
structural insight about the mechanism of inactivation by PnDFP.  
As shown in Figure 4.12, inactivation of PnPyrDC by PnDFP was postulated to occur 
through irreversible modification of the ThDP cofactor at C2 (25). In effect, it acts as a mechanism-
based inhibitor in which the initial steps of the inactivation reaction follow the proposed 
mechanism of catalysis with standard 2-ketoacid substrates. First the ThDP ylid performs a 
nucleophilic attack on the carbonyl of PnDFP to form a tetrahedral intermediate which then 
undergoes decarboxylation. If pyruvate was used, this would result in the formation of the 
carbanion/enamine intermediate which would then become protonated. However, with PnDFP, 
decarboxylation is proposed to be concerted with the loss of a fluoride ion. Finally, this results in 
the formation of an “enolThDP” intermediate, which can tautomerize to form 
phosphonofluoracetylThDP (Figure 4.12 A).  
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Figure 4.12: Proposed mechanisms of A) inactivation of PnPyrDC by PnDFP, and B) formation 
of acetate from β-fluoropyruvate by the E1 component of PDH. 
 
 
104 
 
The loss of the fluoride ion and subsequent formation of the enolThDP complex is similar 
to the proposed mechanism of acetate formation (Figure 4.12 B) by the E1 component of PDH 
when incubated with β-fluoropyruvate (26,30). β-fluoropyruvate appears to inhibit the E1 
component of PDH by acting as a slow alternate substrate ultimately resulting in the formation of 
acetate through addition of a water molecule following loss of the fluoride ion. Conversely, 
reaction of PnPyrDC with PnDFP was shown to cause irreversible inactivation of PnPyrDC 
making it a true inhibitor instead of an alternate substrate. The irreversible nature of the inhibition 
indicates that the phosphonofluoroacetylThDP complex is not likely to break down to form 
phosphonofluoroacetate the same way that acetylThDP breaks down to form acetate in the E1 
component of PDH. 
 
 
Figure 4.13: Electron density fit (1 σ) of the enolThDP complex. 
As seen in Figure 4.13, the electron density stemming from C2 was determined to be from 
the enol/keto tautomers of phosphonofluoroacetylThDP. The moderate resolution of the structure 
makes determination of whether the complex exists primarily in the enol or keto form difficult. It 
is likely that both tautomers exist in significant amounts and the electron density represents an 
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average between them. Given that the geometry of the carbon bound to the fluorine and phosphate 
moieties will be different, a higher resolution structure may provide more insight into the 
distribution of keto and enol tautomers. In the enol form, the form modeled in Figure 4.13, this 
carbon is sp2 hybridized and the fluorine, phosphate, and alcohol groups lie on the same plane. In 
the keto form, however, this carbon will be sp3 hybridized and the geometry would be tetrahedral. 
It should also be noted that, without appropriate resolution, it is difficult to speculate on the 
stereochemistry of the keto tautomer, i.e., would it be in the (R)-, or (S)- configuration. 
4.2.4 Crystals soaked with β-fluoropyruvate 
In a final experiment, crystals of KpALS were soaked in β-fluoropyruvate for 5 minutes 
before being flash frozen in liquid nitrogen as described in Chapter 2. These crystals diffracted to 
1.75 Å, and the model was refined to a final Rwork/Rfree of 0.151/0.189 using the approach outlined 
in section 2.7.4. As with the crystals soaked with pyruvate and PnDFP, upon molecular 
replacement and subsequent placing of the ThDP cofactor, extra electron density was observed 
stemming from C2 of the ThDP cofactor. However, in contrast to the crystals soaked with 
pyruvate, this extra density was only observed in one of the two monomers in the asymmetric unit. 
The second monomer was found to contain unmodified ThDP. The extra density was determined 
to belong to a fluorohydroxyethylThDP (FHEThDP) complex (Figure 4.14).  Finally, no evidence 
of the tricyclic form of ThDP was observed. 
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Figure 4.14: A) Chemical representation and B) Electron 
density fit (1 σ) of the FHEThDP complex. 
 
Observation of the FHEThDP complex was somewhat unexpected as previous studies 
using β-fluoropyruvate showed the loss of the fluoride group following decarboxylation in the E1 
component of the pyruvate dehydrogenase complex from E. coli (26,30). The loss of the fluoride 
ion was shown to result in formation of acetylThDP and the eventual release of acetate (Figure 
4.12). The intermediate observed here would be expected if the final product were to be 
fluoroacetaldehyde in a reaction directly analogous to that catalyzed by pyruvate decarboxylase. 
While β-fluoropyruvate does act as an inhibitor of KpALS (see Chapter 3), the mechanism of 
inhibition is currently not known. Additionally, it has not been established whether incubation with 
β-fluoropyruvate results in either the loss of a fluoride ion, or the formation of acetate. However, 
the inhibition was found to be reversible by dilution assay indicating that β-fluoropyruvate, unlike 
PnDFP is unlikely to be a mechanism-based inhibitor.  
Surprisingly, and unlike the crystals soaked with pyruvate in which ALThDP is found in 
all active sites, FHEThDP is only observed in one of the two monomers in the asymmetric unit 
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and thus only two of the four monomers in the tetramer. At first glance, this provides evidence that 
ThDP-dependent enzymes do not use all active sites simultaneously. It has been reported the 
decarboxylase family of ThDP-dependent enzymes show alternating-site reactivity, with negative 
cooperativity between the sites (31,32). Consequently, if true, in a tetramer such as KpALS, only 
2 of the 4 active sites would be occupied at any given time during a catalytic cycle. More 
specifically, only one site in each functional dimer would be occupied, i.e., one of the two sites in 
pairs A-B and C-D (Figure 4.6). However, this is not the pattern that is observed in this instance. 
Here, the occupied sites are found in the A-B dimer, while the C-D dimer contains unreacted 
ThDP. This immediately suggests two possibilities. First, alternating-sites reactivity does not 
express itself in KpALS in the same fashion as the other enzymes for which alternating-site activity 
was observed. Second, some other factor led to the observation of only one dimer containing a 
reaction complex. Close inspection of the structure indicates that the latter explanation is the more 
likely.  
An intriguing observation is that the C-terminal residues 555-559, normally a disordered 
region, form an alpha helix in the monomers containing unmodified ThDP.  As shown in Figure 
4.15 the helix that appears to close over the active site and completely block substrate access to 
the site. From this point, the monomers containing the closed active site will be referred to as the 
“closed” structure, while monomers without the ordered C-terminal helix will be referred to as the 
“open” structure. 
 
 
Figure 4.15: Space filling model showing the closure of the active site by residues the 
C-terminus. Dimers containing FHEThDP (green) and unmodified ThDP (orange) were aligned 
in UCSF Chimera (33). A) Shows the closed structure of the active site, and B) Shows the open 
structure of the active site. 
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When aligned, the dimers appear reasonably similar with an RMSD of only 0.703 Å over 
all residues. Interestingly, the C-terminus is not the only region that shows deviation when the sets 
of dimers are aligned. While the interior loops, particularly those surrounding the active site, align 
with almost no deviation, many solvent accessible loops show positional changes ranging from 2.5 
Å to over 8 Å. Two of the loops showing these movements also show varying degrees of disorder. 
For example, in the open structure residues 116-122 form a disordered loop that cannot be 
modeled. In the closed structure however, the residues form an ordered α-helix (Figure 4.16 A) 
that sits directly across the substrate channel from the C-terminal residues.  
Differences also arise with residues 354-366. In the open structure these residues form the 
end of an ordered α-helix, while in the closed structure all α-helical character is lost  In fact, 
residues 358-366 in the closed structure show too little electron density to be modeled (Figure 4.16 
B).  
 
 
Figure 4.16: Movement of loops A) 116-122, and B) 354-366. Residues from closed structure are 
shown in blue. Residues from open structure are shown in green. 
 
Closure of the active site does not necessarily explain the movement of these loops. More 
likely, movement of the loops potentially explains the closure of the active site. This leads to the 
question of what forces are inducing the loop movements. Indeed some of the same mobility of 
the surface loops is observed when dimer components of the structure from crystals soaked with 
pyruvate are aligned, indicating that the loop movements and the closure of the active site may be 
unrelated. However, the movements in crystals soaked with pyruvate appear smaller in magnitude 
than those observed in the crystals soaked with β-fluoropyruvate.  
One simple explanation for these observations is that crystal-packing forces cause the 
closure of the active site. This seems unlikely as no other structures of KpALS show this closed 
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C-terminal conformation. However, this possibility cannot be eliminated as the increased 
resolution and moderately lower B-factors from these crystals indicate a higher degree of order, 
and thus potential observation of regions in which previous models showed little or no electron 
density. 
An alternative, and more intriguing, explanation for the loop movement could lie in the 
possibility of regulatory phosphate-binding site. In all structures of KpALS, except from crystals 
soaked with β-fluoropyruvate, a phosphate molecule is observed bound to each monomer of the 
enzyme. Initially, the site was not considered significant and the bound phosphate was potentially 
only present because the enzyme was stored in phosphate buffer. In crystals soaked with β -
fluoropyruvate however, two of the four phosphate-binding sites are occupied by a molecule of β-
fluoropyruvate, while the other two remain occupied by phosphate. Intriguingly, the sites occupied 
by β-fluoropyruvate belong to the same monomers containing the closed active site. Only the 
monomers containing phosphate in the site showed the open conformation of the active site. 
Additionally, many of the solvent accessible mobile loops surround the phosphate binding site 
(Figure 4.17).  
Currently, this evidence suggests that it is possible that displacement of the phosphate 
molecule in the active site may be inducing changes in residues surrounding the active site. These 
observations, in concert with the buffer-dependent change of kinetic profile of KpALS, as 
discussed in Chapter 3, suggest that this site may be important for regulation of the enzyme.  
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Figure 4.17: Movement of loops surrounding the phosphate binding site. Residues in green are 
from dimer bound with phosphate (orange). Residues in blue are from dimer bound to 
β-fluoropyruvate. For clarity, β-fluoropyruvate is not shown. 
4.3 Investigation into the phosphate binding site as the site of allosteric activation 
The observation of sigmoidal kinetics only in phosphate buffer (see Chapter 3) as well as 
the displacement of the bound phosphate molecule in the crystal soaked with β-fluoropyruvate led 
to a mutagenesis study to probe the possibility of the phosphate binding site as the source of the 
buffer dependence of the kinetic profile.  
Potentially-important residues were identified by comparing the binding mode of 
phosphate to that of β-fluoropyruvate (Figure 4.18). Residues Arg259, Gln266, Arg352, and 
Tyr406 were found to have hydrogen bond interactions with the bound phosphate. Of these, only 
Arg259 and Arg352 showed direct interactions with β-fluoropyruvate. However, binding of β-
fluoropyruvate is additionally accompanied by significant movement of the side chain of Gln266. 
Tyr406 showed little movement upon displacement of phosphate, and appears to have no 
interaction with β-fluoropyruvate. 
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Figure 4.18: Hydrogen bond interactions of A) phosphate, and B) β-fluoropyruvate in the 
phosphate binding site. 
 
 While hydrogen bond interactions are observed with each of the oxygen atoms in 
the phosphate molecule, such interactions are only observed with the carboxylate group in 
β-fluoropyruvate. This is particularly interesting when considering that the carboxylate group in 
acetate could potentially allow the compound to bind in a similar manner, possibly leading to the 
acetate activation discussed in Chapter 3. Additionally, the β-fluoropyruvate binding mode 
suggests that this site could also be the origin of the substrate activation required when the kinetics 
of KpALS are measured in phosphate buffer. Given that pyruvate and β-fluoropyruvate differ only 
by the presence of the fluorine atom, it is likely that pyruvate binds and displaces phosphate in an 
almost identical way.  
 To investigate this, site-directed mutagenesis was performed on Arg259, Gln266, 
and Arg352 to determine the contribution of each residue to the buffer dependence on kinetic 
profile. Using the primer sequences listed in Table 4.2, theses residues were mutated to alanine in 
an attempt to eliminate any contribution to potential binding of phosphate, pyruvate, or acetate in 
the site. Mutagenesis was performed as described in Chapter 2. 
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Table 4.2: Sequences of primers used for mutagenesis of phosphate binding site residues.* 
Primer Name Sequence 
  
R259A Forward 5’-TCTCGCTTCGCCGGCgccGTTGGGCTGTTTAAC-3’ 
 
R259A Reverse 5’-GTTAAACAGCCCAACggcGCCGGCGAAGCGAGA-3’ 
 
R352A Forward 5’-GAGATCCTCCGCGACgctCAGCACCAGCGCGAG-3’ 
 
R352A Reverse 5’-CTCGCGCTGGTGCTGagcGTCGCGGAGGATCTC-3’ 
 
Q266A Forward 
 
5’-GTTTAACAACgcGGCCGGGGACCGTCTGCTaCAGCTCGCCGACC-3’ 
 
Q266A Reverse 
 
 
5’-GGTCGGCGAGCTGtAGCAGACGGTCCCCGGCCgcGTTGTTAAAC-3’ 
 
*Lowercase bases indicate a mismatch with the template DNA. 
 
In total, five KpALS variants were constructed: R259A, R352A, Q266A, R259A/R352A, 
and R259A/R352A/Q266A. Each of the variants was expressed and purified in the same manner 
as the wild type enzyme. Once purified, the variants were assayed in the same three buffer systems 
as the wild type enzyme: acetate, MES and phosphate at pH 6.0 using the CD method following 
the formation of (S)-acetolactate. The plots, and the steady-state kinetic parameters derived from 
them, are presented in Figure 4.19 and Table 4.3, respectively. 
In acetate buffer, only variants containing the R259A mutation showed any significant 
change in Km value. R259A showed a four-fold increase in Km, while R352A showed a Km 
relatively close to that obtained for the wild-type enzyme. In phosphate, the R259A mutation 
resulted in Michaelis-Menten kinetics, i.e., sigmoidal kinetics were not observed for this variant. 
The kinetics in MES were more difficult to evaluate as the near linear plots indicated that the Km 
value is well in excess of 120 mM. Higher pyruvate concentrations were tested, however using 
over 150 mM resulted poor data quality due to its absorbance at 310 nm. 
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The R352A variant was found to be largely similar to wild-type KpALS in both acetate and 
phosphate buffers. However, in MES, the kcat and Km values both showed increases. Most 
importantly, as was observed for the wild-type enzyme, R352A showed Michaelis-Menten kinetics 
in acetate and MES, and sigmoidal kinetics in phosphate buffer. 
Perhaps the most interesting feature of the single variants was the appearance of sigmoidal 
kinetics for Q266A in all three buffers. The S05 and kcat values in MES and phosphate were similar, 
while a lower S05 value and higher kcat value were found in acetate. It is notable that the Hill 
coefficients for reaction in acetate and MES buffers were lower than that observed in phosphate 
buffer, although the meaning of that observation is still unclear. 
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Figure 4.19: Plots of steady-state kinetic data for each allosteric site variant in acetate (black), 
MES (green), and phosphate (blue). 
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Table 4.3: Steady-state kinetic parameters of allosteric site variants. 
Acetate 
Variant Km or S05 (mM) kcat (s-1) kcat/Km n 
Wild Type 8 ± 2 310 ± 20 39 - 
R259A 49 ± 9 270 ± 20 6 - 
Q266A 19 ± 3 250 ± 20 13 1.5 
R352A 18 ± 1 480 ± 10 27 - 
R259A/R352A 40 ± 5 240 ± 10 6 - 
R259A/R352A/Q266A 130 ± 30 130 ± 20 1 - 
MES 
Variant Km or S05 (mM) kcat (s-1) kcat/Km n 
Wild Type 19 ± 1 290 ± 30 15 - 
R259A* - - 0.9 - 
Q266A 61 ± 6 230 ± 20 4 2.2 
R352A 67 ± 4 480 ± 10 7 - 
R259A/R352A 66 ± 5 190 ± 7 3 - 
R259A/R352A/Q266A* - - 0.2 - 
Phosphate 
Variant Km or S05 (mM) kcat (s-1) kcat/Km n 
Wild Type 37 ± 8 230 ± 20 6 2.2 
R259A 141 ± 23 330 ± 40 2 - 
Q266A 64 ± 2 155 ± 5 2 2.9 
R352A 41 ± 2 138 ± 7 3 2.1 
R259A/R352A 48 ± 5 191 ± 8 4 - 
R259A/R352A/Q266A 69 ± 5 85 ± 3 1 - 
n – Hill coefficient 
* kcat/ Km was calculated as the slope of the linear kinetic plots (i.e., V/K conditions). 
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Neither the double (R259A/R352A) nor the triple (R259A/Q266A/R352A) variant showed 
any evidence of sigmoidal kinetics. The double variant was interesting in that the Km values in 
MES and phosphate buffers were significantly lower than that of the R259A variant suggesting 
that the increased sensitivity to MES buffer observed in the R259A variant was lost after 
introduction of the R352A mutation. In acetate, the triple variant showed a ~10-fold increase in 
Km value when compared to the wild type enzyme. This was the largest increase in any of the 
variants in this buffer. In fact, this is the only variant tested that shows a Km value lower in 
phosphate than in acetate. Finally, the triple variant showed the lowest kcat values of all variants. 
Taken together, these results indicate that the phosphate binding site is likely to be the site 
of allosteric activation in KpALS. Mutation of Gln266 to alanine results in sigmoidal kinetics in 
all conditions tested, while mutation of Arg259 to alanine results in Michaelis-Menten kinetics in 
all conditions. In fact, all variants carrying the R259A mutation showed Michaelis-Menten kinetics 
in all conditions, even when the Q266A mutation was also present. Clearly, Gln266 and Arg259 
are important for allosteric regulation of the enzyme. Conversely, the R352A single variant showed 
no effect on the kinetic profile, and only a minimal effect on Km values. 
It is interesting that while the R259A single variant showed no evidence of sigmoidal 
kinetics, it showed one of the largest buffer effects on Km values ranging from ~50 mM (acetate) 
to an estimated 400 mM (MES). Conversely the R259A/R352A double variant showed the 
smallest range of Km values. This indicates that, while Arg259 has a profound effect on the 
requirement for allosteric activation in phosphate, and influences buffer effects overall, it is not 
the only residue responsible for these effects. It required a combination two mutations, R259A and 
R352A, to see the sigmoidal kinetics and buffer effects on kinetic parameters effectively 
eliminated. However, addition of a third mutation, Q266A, led to some odd effects. For example, 
the pyruvate Km value for reaction in MES buffer increased greatly, returning that observed for the 
R259A variant, while the kcat values were at least a 2-3-fold lower than those observed for any 
other variants. 
4.4 Summary and Conclusions 
This chapter discusses three X-ray structures of KpALS solved following the soaking of 
ALS crystals with three compounds: pyruvate, phosphonodifluoropyruvate, and β-fluoropyruvate. 
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All three structures showed the presence of covalent reaction intermediate complexes of ThDP in 
the active site.  
Crystals soaked with pyruvate resulted in the observation of a tricyclic form of ALThDP. 
This was the second time the tricyclic dihydrothiachrome form of ThDP had been observed in 
KpALS, and only the third time for ThDP-dependent enzymes in general. Overall, the observation 
of this intermediate is important as it provides insight into the binding mode of pyruvate as the 
acceptor substrate in the formation of (S)-acetolactate. Unexpectedly, it was discovered that, in 
addition to hydrogen bonding, hydrophobic interactions appear to play a significant role in 
positioning of the acceptor to ensure the (S)-enantiospecificty of the reaction. Finally, the ALThDP 
complex permitted the identification of those active site residues likely to be involved in substrate 
specificity. The analysis and subsequent testing of these observations are discussed in Chapter 5. 
Crystals soaked with phosphonodifluoropyruvate showed evidence of a trapped 
phosphonofluoroacetylThDP intermediate. The intermediate provided evidence in support of the 
proposed mechanism of inactivation of phosphonopyruvate decarboxylase by PnDFP. 
Unfortunately, the structure was not of sufficient resolution to determine whether the keto or enol 
tautomer of the intermediate was the major contributor to its stability although, on balance, the 
latter was more likely.  
In a final soaking experiment, crystals soaked with β-fluoropyruvate exhibited a number 
of surprising and noteworthy features. These included a FHEThDP intermediate in two of the four 
active sites in the KpALS tetramer, β-fluoropyruvate displacing phosphate in two of its four 
possible binding sites, and a C-terminal helix closing over two of the four active sites. The 
observation of the FHEThDP intermediate was somewhat surprising as it was expected that the 
fluorine would be eliminated following decarboxylation as was seen in the E1 component of PDH. 
Currently, it is unknown whether the retention of the fluorine in KpALS is due to the enzyme being 
in crystalline form, or if the enzyme simply catalyzes a different reaction with β-fluoropyruvate.  
Observation of β-fluoropyruvate bound in place of phosphate is interesting for two reasons. 
First, the enzyme displays sigmoidal kinetics when assayed in phosphate buffer, but exhibits 
Michaelis-Menten kinetics when it is assayed in acetate buffer at the same pH. This suggests that 
phosphate may be playing some sort of regulatory role. The second relates to the observation that, 
in monomers where β-fluoropyruvate displaces phosphate, a C-terminal helix closes over the 
active site. It is currently unclear whether the two events are related. This region is generally 
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disordered in other published structures of ALS and it is feasible that some other force such as 
crystal packing may be contributing. That said, the link is striking and, to explore this further, a 
mutagenesis study on the phosphate binding site was carried out.  
Lastly, a mutagenesis study was performed that provided evidence that the phosphate 
binding site is indeed the site responsible for the requirement of substrate activation in KpALS. 
Initially, it was clear that Arg259 and Gln266 are both involved in allosteric regulation by this site. 
While the R259A variant showed a significantly increased Km value in MES buffer, it exhibited 
no evidence of sigmoidal kinetics. Conversely, the Q266A variant required substrate activation in 
all conditions tested. The R352A variant showed wild-type like kinetic patterns, and showed little 
effect on Km and kcat values indicating that Arg352, by itself, has little effect on binding. However, 
when in concert with the R259A mutation in the R259A/R352A double variant, the sensitivity to 
MES and phosphate buffers that was observed with the R259A variant was eliminated. Further, 
introduction of the Q266A mutation to the double variant saw the restoration of sensitivity to MES, 
along with a 2-3-fold reduction in kcat values in both acetate and phosphate buffers. Taken together, 
these results indicate that the phosphate binding site is most likely to be responsible for the 
requirement of substrate activation in KpALS and that all three residues examined, Arg259, 
Gln266, and Arg352, are important in the buffer effects exhibited by the enzyme. 
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CHAPTER 5.  GROWTH COMPLEMENTATION STUDIES ON 
ACTIVE SITE VARIANTS OF KLEBSIELLA PNEUMONIAE 
ACETOLACTATE SYNTHASE 
5.1 Introduction 
Acetohydroxyacid synthase (AHAS), a ThDP-dependent enzyme, has long been known as 
the target of the broadly used imidazolinone and sulfonylurea herbicides (1-7). These classes of 
herbicides are used worldwide and accounted for approximately $2.3 billion in annual sales in 
2014 (8). These compounds are quite potent with application rates of 10-100 g per hectare and 
show low toxicity toward humans. In fact, some non-herbicidal derivatives of the sulfonylureas 
are even used in the treatment of diabetes mellitus type 2 (9,10). The relative safety of these 
compounds makes them attractive for use in fields to control unwanted weed growth. However, 
many crops of interest are also negatively affected by these compounds, making non-targeted 
treatment of a whole field difficult. This problem could be mediated if a resistant form of the 
desired crop were to be engineered. Planting of the engineered crop would then allow for 
nonspecific application of these herbicides to a whole field without negative effects toward the 
engineered plant. This chapter describes the initial steps toward achieving such a goal including: 
i) identification of an enzyme resistant to the herbicidal inhibitors, ii)  establishment of a growth 
complementation assay to probe for AHAS activity in knockout stains of E. coli, and iii) 
preliminary mutagenesis studies on engineering an enzyme capable of fulfilling the biosynthetic 
role of AHAS while maintaining resistance to the sulfonylurea and imidazolinone herbicides.  
5.1.1 Basis for herbicidal activity of AHAS inhibitors 
In plants, bacteria and fungi, branched chain amino acids (BCAAs) are synthesized from 
two compounds, acetolactate and acetohydroxybutyrate (Figure 5.1). 
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Figure 5.1: Biosynthesis of A) valine, B) leucine, and C) isoleucine starting with pyruvate and α-
ketobutyrate. Abbreviations used are: AHAS, acetohydroxyacid synthase; KARI, ketol-acid 
reductoisomerase; DH, dihydroxyacid dehydratase; BCAT, branched-chain amino acid 
aminotransferase; IPMS, 2-isopropylmalate synthase; IPMI, isopropylmalate isomerase; IPMD, 
3-isopropylmalate dehydrogenase. 
 
Figure 5.1 shows that acetolactate is a precursor to valine and leucine, while 
acetohydroxybutyrate is a precursor to isoleucine. Acetolactate is formed by the condensation of 
two molecules of pyruvate, while acetohydroxybutyrate is formed by the condensation of one 
molecule of pyruvate and one molecule of α-ketobutyrate. The formation of both compounds is 
catalyzed by AHAS, the first step in the pathway.  
One of the interesting and unique features of these pathways is the fact that the same 
enzyme cascade catalyzes the formation of both valine and isoleucine, as well as many of the 
precursors to leucine. In order to maintain a consistent level of each amino acid, the pathways are 
heavily regulated, although the mechanisms of regulation are not completely understood (9). 
Accordingly, inhibition of the enzymes, AHAS, ketol-acid reductoisomerase (KARI), 
dihydroxyacid dehydratase (DH), or branched-chain amino acid aminotransferase (BCAT) would 
likely prevent formation of not one, but all three amino acids. Since these amino acids are essential 
for growth, inhibition of this pathway would, presumably, lead to death of the target organism. 
By contrast, mammals do not possess these biosynthetic pathways; they must acquire these 
amino acids through dietary means (9). Targeting these pathways and their regulation mechanisms 
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provides an opportunity for development of herbicidal and antibacterial compounds with low 
human toxicity. Indeed, at least two enzymes in these pathways, AHAS and KARI, have been 
targeted in herbicide development (11). Additionally, the enzyme catalyzing the final step in valine 
and isoleucine biosynthesis, BCAT, has been identified as susceptible to inhibition by PLP 
inactivators. However, BCAT is a less desirable target as mammals express homologues of this 
enzyme for amino acid degradation pathways (12), thus increasing the possibility of toxicity 
towards humans and animals.  
The imidazolinone and sulfonylurea herbicides are two classes of AHAS inhibitors that 
prevent the formation of acetolactate and acetohydroxybutyrate for BCAA production. They have 
been shown to be potent herbicides with low toxicity toward mammals. Reported LD50 values for 
the sulfonylurea compounds are as high as 6 g/kg of body weight in rats (9), likely this is due to 
the lack of mammalian homologues of AHAS (13).  
Interestingly, although plants and bacteria use the same pathways to synthesize the 
BCAAs, growth studies on various bacterial strains have shown differential levels of bacterial 
toxicity when exposed to these herbicides. This indicates some level of specificity toward the 
plant-derived enzymes, differential levels of cell uptake, or the presence of degradation pathways. 
As many studies report similar levels of inhibition of purified AHASs from plants and bacteria, 
degradation pathways and varied levels of cellular uptake are likely explanations for the disparity 
in toxicity. Regardless, these studies showed that many of the compounds still have significant 
toxic effects toward many bacteria (14,15). 
Off-target toxic effects, i.e., undesired toxicity toward crops such as corn, beans, etc., by 
these herbicides are reported at concentrations as low as 1/100 of a typical effective dose (16). 
This makes whole field treatment an unattractive option in most cases, as it would cause a large 
reduction in total crop yield. Therefore, to allow for broad application to whole fields will 
necessitate the development of crops resistant to these herbicides. 
5.1.2 Design of herbicide resistant crops 
Development of herbicide-resistant plants has previously seen wild success. In 1974, 
glyphosate, or trade name Roundup®, was brought to market by Monsanto. As with the 
sulfonylurea and imidazolinone herbicides, glyphosate was quickly found to be a “broad spectrum” 
herbicide effectively killing almost every plant on which it was applied. Unfortunately, glyphosate 
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is as effective at killing crops as it is at controlling weeds. To remedy this, Monsanto released the 
first glyphosate resistant “Roundup Ready®” crop in 1996 (17). Since then, the range of Roundup 
Ready® crops has grown and glyphosate has become the most widely-used herbicide around the 
world. However, this widespread and consistent use has led to the emergence of more than 30 
different species of glyphosate-resistant weeds, necessitating the development of new crop 
treatment options (18-20). 
Glyphosate acts by inhibiting 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase, an 
enzyme important in biosynthesis of aromatic amino acids and other essential biological 
compounds (21). It was discovered that while the EPSP synthases from plants are inhibited by 
glyphosate, not all of the orthologues from bacteria were subject to the same inhibition. Eventually, 
a resistant enzyme from Agrobacterium sp. CP4 was identified and inserted into the plant genome, 
conferring herbicide resistance to the host plant (22). 
It is not unreasonable to speculate that, in a similar manner, insertion of an AHAS enzyme 
resistant to inhibition by sulfonylurea and imidazolinone herbicides into a plant genome could 
confer herbicide resistance to that plant. In this chapter, we explore the possibility that acetolactate 
synthase from Klebsiella pneumoniae (KpALS) might act as such an enzyme.  
5.1.3 ALS as a potential replacement for AHAS in herbicide resistant crops 
Like AHAS, ALS catalyzes the ThDP-dependent formation of acetolactate from pyruvate. 
Although they catalyze the same reaction, ALS and AHAS exhibit distinct differences including 
reaction kinetics, as shown in Chapter 3, cofactor dependence, and substrate profile. While these 
differences do not necessarily prohibit the use of ALS as a replacement for AHAS, they should be 
investigated to determine the potential for an ALS, such as KpALS discussed here, to fulfill the 
biosynthetic role of AHAS. 
With the X-ray structure solution of AHAS from a yeast (Saccharomyces cerevisiae) and 
a plant (Arabidopsis thaliana), both in complex with sulfonylurea and imidazolinone herbicides, 
the binding mode of the compounds can be identified (6,7,23). Interestingly the sulfonylurea 
herbicides, specifically chlorsulfuron, do not bind in the active site. Instead they bind in the channel 
leading to the active site, thereby blocking substrate access (6,7,23). Figure 5.2A shows the 
interactions of chlorsulfuron in the active-sites of the AHAS from S. cerevisiae (ScAHAS) and a 
homology model of AHAS from K. pneumoniae (KpAHAS) generated by the PHYRE2 Protein 
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Fold Recognition Server (24) using the ScAHAS:chlorsulfuron structure (PDB ID:1T9B) as the 
template. Even a cursory inspection of the chlorsulfuron binding pocket in both ScAHAS and 
KpAHAS shows that the majority of the enzyme-chlorsulfuron interactions are conserved. Given 
that ScAHAS is inhibited by chlorsulfuron, KpAHAS would be expected to be similarly inhibited.  
The AHAS:chlorsulfuron structures were then aligned with an X-ray structure of KpALS 
(PDB ID: 5WDG) in order to compare binding interactions between the yeast and bacterial AHAS, 
and a bacterial ALS (Figure 5.2B). It was readily apparent that KpALS had several unfavorable 
steric interactions with the inhibitor suggesting that chlorsulfuron is unlikely to be an inhibitor of 
KpALS. 
 
 
Figure 5.2: A comparison of chlorsulfuron binding sites. A) Overlay of ScAHAS with bound 
chlorsulfuron (tan) with aligned homology model of KpAHAS (green). Hydrogen bonds are 
shown as blue lines. B) Model of chlorsulfuron binding in KpALS (blue). Steric clashes are 
shown as red lines. Hydrogen bond and steric clash analyses were performed in UCSF Chimera 
(25). 
 
As seen in Figure 5.2, Arg380 shows strong hydrogen bonding interactions with the 
carbonyl oxygen, one of the nitrogen atoms in the triazine ring, and with the hydroxyl substituent 
on the triazine ring in the inhibitor. Additionally, a strong π-stacking interaction is observed 
between the triazine ring and Trp586. Interestingly, an additional interaction is predicted between 
one of the sulfone oxygens in chlorsulfuron and Lys251 in the model of KpAHAS. While this 
residue is conserved in both KpAHAS and ScAHAS, they are present in different rotamers with 
the residue in ScAHAS pointed away from the herbicide. As such, it is likely that the difference is 
simply a result of the modeling process. 
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In contrast to the picture in AHAS, the putative chlorsulfuron binding-site in KpALS shows 
no obvious hydrogen bond interactions and the aromatic tryptophan residue (Trp586) has been 
replaced by a glutamine (Gln483) thereby removing any possibility of π-stacking interactions. 
Indeed, it appears that almost all of the favorable binding interactions observed in AHAS have 
been replaced with unfavorable interactions in KpALS. The hydrogen bond with Lys251 is 
replaced with a clash with Gln169, and many close contacts are observed between the chlorine of 
chlorsulfuron and Lys36 of KpALS. The latter clash is avoided in AHAS as lysine is replaced by 
an alanine in that position. Given the presence of several strong H-bond and π-stacking 
interactions, and the lack of any obvious steric clashes, it is not surprising that this class of AHAS 
inhibitors generally have reported Ki values in the low nM range (9). 
Surprisingly, a literature search showed no reports of these compounds being tested for 
inhibition of ALS. Accordingly, to test the hypothesis that ALS would not be inhibited by 
compounds of this type, chlorsulfuron was used in a preliminary inhibition study carried out with 
both KpALS and KpAHAS (see sections 2.6.1 and 2.6.2 for a detailed description). 
 
 
Figure 5.3: Steady-state kinetic plots for A) KpALS, and B) KpAHAS in the presence () and 
absence (○) of chlorsulfuron (400 nM). 
 
As expected from the structural analysis, KpALS was essentially unaffected by the 
presence of 400 nM chlorsulfuron. Conversely, KpAHAS was clearly inhibited at that 
concentration. The inhibition appeared competitive in nature, and the Ki for chlorsulfuron was 
determined to be 220 nM. This value is still in the nM range, although it is 10-fold higher than that 
reported for the plant homologue from A. thaliana at 21 nM (26), and ~2-fold higher than that 
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reported for the yeast enzyme (27). These differences may be ascribed to the fact that KpAHAS is 
a bacterial enzyme, possibly with some distinctive yet to be characterized properties. Alternatively, 
they could be due, at least in part, to the fact that these compounds commonly show time-dependent 
inhibition with full inhibition observed only after long incubation periods (28). As this was a 
simple screening for KpALS resistance, no pre-incubation was performed before initial rates were 
measured.  
The role of the FAD cofactor in the AHAS mechanism, is currently the subject of some 
discussion. Certainly it has been implicated in the time-dependent inactivation (29). As can be 
seen in the X-ray structures, binding of the sulfonylurea herbicides blocks substrate access to the 
active site thereby causing the initial inhibition. This is followed by time-dependent oxidation of 
the FAD cofactor, which is required to be in its reduced form during catalysis (23,29-31). Given 
that ALS does not generally contain FAD (32) it is unlikely that similar time-dependent 
inactivation will be seen in KpALS. The lack of FAD and absence of any rapid-onset inhibition 
indicates that it is possible that KpALS will remain active during any in vivo treatment with the 
sulfonylurea herbicides. 
While not specifically germane to the subject at hand, it is interesting to report on the 
current debate about the role of FAD. Why AHAS requires reduced FAD for catalysis is still 
largely unknown, although it has generally been accepted that the cofactor plays a structural role 
in the reaction rather than an active redox role (9,33). In the past year or so, a new reaction 
mechanism has been proposed for ScAHAS, a mechanism that disputes the idea that the role of 
FAD is purely structural (34). This mechanism suggests that the FAD cofactor and an oxygen 
molecule bound in the active site participate in two single electron transfers each in the catalytic 
cycle (Figure 5.4).  
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Figure 5.4: Proposed mechanism in ScAHAS involving FAD. 
Reproduced from Lonhienne et al. (34). 
 
This new mechanism is quite different to the widely accepted mechanism (Figure 1.15) 
that was discussed in Chapter 1. While it does provide an explanation as to why reduced FAD is 
required for AHAS activity, previous experiments indicate that it might not be completely correct. 
NMR studies on AHAS from E. coli (EcAHAS) showed clearly the presence of the LThDP 
intermediate (35,36). However, if the newly proposed mechanism was correct, this observation 
would be unlikely as attack on the first substrate is proposed to be in concert with decarboxylation 
(34), meaning that the LThDP intermediate should not be observed. 
A similar concerted mechanism is also proposed for attack on the second substrate. In the 
same way, this would prevent the observation of ALThDP, yet it was also seen in the NMR 
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experiments (35,36). This indicates either the bacterial EcAHAS and the fungal ScAHAS operate 
by different mechanisms, or that the concerted steps in the new mechanism cannot be correct. It 
would be informative to see the NMR experiments carried out on ScAHAS. If LThDP/ALThDP 
were to be observed in that study it would mitigate strongly against the new mechanism. Certainly, 
if proved to be correct, this mechanism challenges the long-held belief that ALS and AHAS 
employ the same reaction mechanism. Put simply, that would be impossible as ALS does not 
possess, or show a need for, FAD. 
5.2 Establishment of a growth complementation assay 
After finding that KpALS appears resistant to inhibition by chlorsulfuron in vitro, the next 
step in testing the viability of using ALS to confer herbicide resistance is to determine whether it 
is able to act as a functional AHAS in vivo. One potential problem may preclude the enzyme being 
used as a replacement for AHAS is that ALS is known to have a strong preference for pyruvate, 
not α-ketobutyrate, as the acceptor substrate. This results in acetolactate being the predominant 
product (37-40), although it is not impossible that some acetohydroxybutyrate can be produced. 
The origins of this specificity are yet to be established, although there does appear to be some 
differences in the active sites of AHAS and ALS. Regardless, the ability of ALS to act as a 
functional AHAS in vivo has never before been examined. Testing this would be a major 
undertaking if one were to insert KpALS into a plant genome to test viability in plants directly.  
Fortunately, a simpler system can be used in which formation of acetolactate and 
acetohydroxybutyrate can be tested using knockout strains of E. coli (41).  
To take this further, four E. coli strains were identified that lack the ability to form 
isoleucine and valine. The strains are derivatives of E. coli K12 and contain one or more mutations 
of the three E. coli AHAS isozymes, thereby rendering them unable to form acetolactate and 
acetohydroxybutyrate. These strains are designated MI168 (ilvH612, λ-, relA1, thiE1) (42), MI253 
(thr-10, araC14, ilvI614, ilvH612, λ-, relA1, thiE1) (42), MI262 (leuB6(Am), ilvI614, ilvH612, λ-, 
relA1 spoT1, ilvB619, ilvG605(Am), ilvG603(Act), thiE1) (43), and FD1062 (araC14, ilvI614, 
ilvH612, λ-, glyA18, relA1, spoT1, ilvB619, bglR20, rbs-5: :Tn5, ilvG468(Act), thiE1 (44). Sikdar 
and Kim (41) showed that transformation of a plasmid carrying a functional AHAS gene into each 
of these strains allows growth on minimal media lacking isoleucine and valine.  
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5.2.1 Construction of the pBADKpALS expression vector 
As these knockout strains do not contain the λ(DE3) lysogen, protein expression under 
control of the T7 promoter cannot be used. To overcome this, the KpALS gene was cloned into 
the pBAD/Myc-HisA expression vector, which uses the araBAD promoter. When using this 
vector, protein expression is induced in the presence of arabinose, and levels of expression can 
easily be modulated by manipulating the concentration of arabinose in the growth media (45). 
Before ligation into the pBAD vector, PCR mutagenesis was used to remove an internal 
Nco1 restriction site from the KpALS gene. Mutagenesis primers were designed according to the 
QuikChange protocol and can be seen in Table 5.1. After removal of the internal Nco1 site, plasmid 
pBADKpALS was constructed as described in section 2.2.2. 
 
Table 5.1: PCR mutagenesis primers for removal of internal Nco1 site in the KpALS gene. 
Mismatches with template DNA are shown in lower case. 
Primer Name Sequence 
 
KpALS*  -Nco For 5’-GCGCgATGGCGGTGAAAGTGGATGTTTCTGACC-3’ 
 
KpALS*  -Nco Rev 
 
5’-GGTCAGAAACATCCACTTTCACCGCCATcGCGC-3’ 
 
5.2.2 Expression testing and strain selection 
Following construction of the pBADKpALS expression vector, it was transformed into E. 
coli BL21(DE3) to check the ability of the system to express the KpALS. The resulting colonies 
were used to inoculate small-scale expression cultures (5 mL) with and without 1% arabinose. 
Excellent over-expression was observed with no evidence of leaky expression in cultures without 
arabinose. 
To test protein expression in the target system, the pBADKpALS plasmid was transformed 
into each of the four AHAS deficient E. coli strains (MI168, MI253, MI262, and FD1062) together 
with E. coli Bl21(DE3) as a positive control. Cells were grown in 5 mL cultures of LB media 
overnight with and without addition of 1% arabinose. Crude cells extracts were then analyzed by 
SDS-PAGE to check for protein expression (Figure 5.5).  
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Figure 5.5: SDS-PAGE gel showing crude extracts of cells from expression test. A description of 
the lane contents can be found in the text. Expression of KpALS can be seen in lanes 3, 5, 7, 9, 
and 11. 
 
Lane 1 contains Mark12™ protein standards (Life Technologies). Lane 2 contains a sample 
of transformed MI168 cells from a culture grown without (-) arabinose while lane 3 contains a 
sample of the same cells from culture grown with (+) arabinose. This (-)/(+) pattern continues 
across the gel. Lanes 4 and 5 contain MI253 cells; Lanes 6 and 7, MI262 cells; lanes 8 and 9 
contain FD1062 cells; lanes 10 and 11 contain BL21(DE3) cells. The cultures containing 1% 
arabinose saw a heavy band appear between 55 and 66 kDa. This is consistent with arabinose-
mediated expression of KpALS which has a calculated molecular mass of ~62.5 kDa.  
Although the knockout strains all showed good expression of KpALS (Figure 5.5), MI262 
was chosen as the optimal strain with which to carry out growth complementation experiments. 
This decision was made on two grounds. First, MI262 contains more mutations in the AHAS gene 
than MI168 and MI253, making it less likely to present false positives through reactivation of the 
AHAS genes. Second, although strain FD1062 contained the same number of AHAS mutations, it 
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exhibited a strange phenotype in which colonies were not well defined on the agar plates, making 
it overall inferior to MI262. 
5.2.3 Growth on minimal media 
The initial expression test cultures were grown in rich media (LB), i.e., the cells were 
provided all amino acids required for growth. To test the ability of the expressed KpALS to act as 
a functional AHAS, the cells must be grown in media without isoleucine and valine supplements. 
As such, the expression test cultures were streaked on plates containing M9 minimal media without 
isoleucine and valine. The plates also contained 1% arabinose to induce protein expression (See 
section 2.6.4). After 36 hours, the only strain showing growth on these plates was BL21(DE3).  
This result was expected if KpALS is not able to act as a functional AHAS. Presumably, 
this was due to KpALS not being able to form enough acetohydroxybutyrate for isoleucine 
synthesis. However, before this conclusion could be drawn, other factors had to be considered as 
potential explanations for the lack of cell growth. To understand these required the screening of 
multiple factors such as, arabinose concentration, supplementation with isoleucine and/or valine, 
and presence of selection antibiotic. The number of conditions to be tested led to the establishment 
of a liquid media based analysis employing a 96-well plate reader. The plate reader was set to take 
optical density measurements at 595 nm every 15 minutes over a 24 hour period. Throughout the 
growth period the 96-well plates were maintained at 37 °C with shaking between measurements. 
The readings were then plotted and growth curves were obtained. 
To eliminate the possibility of slow or negligible growth being the result of too much 
selection pressure, the concentration of arabinose and the presence of antibiotic were tested as 
experimental variables. As the arabinose concentration controls expression levels, it was 
considered that, when cells were grown in minimal media, a high arabinose concentration could 
exhaust cellular stocks of amino acids by inducing too much protein expression. Although less 
likely, the effect of the ampicillin antibiotic was tested also, as the over-expression of β-lactamase 
could have a similar effect.  
To test these possibilities, MI262 cells carrying the pBADKpALS plasmid were grown in 
minimal media while the arabinose concentration was varied from 0.2% to 0.00002% in ten-fold 
increments, in the presence and absence of ampicillin. The plate layout can be seen in Table 5.2, 
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and the growth curves can be seen in Figure 5.6. In Table 5.2 each box represents a unique 
condition tested in triplicate.  
The data presented in Figure 5.6 shows that arabinose concentration and presence of 
ampicillin had little to no effect on growth in minimal media. Most importantly however, the 
experiment confirmed that KpALS is not able to complement growth in media lacking both 
isoleucine and valine, concluding that direct replacement of AHAS by wild type ALS is not a 
viable option to confer herbicide resistance.  
  
Table 5.2: Plate layout for testing arabinose concentration and presence of ampicillin on MI262 cell growth in minimal media. 
Each box represents conditions tested in triplicate. 
 1 2 3 4 5 6 7 8 9 10 11 12 
A Water Blank Media -Ilv Media +Ilv Media +Ilv +Amp 
B MI262 -Ilv MI262 +Ilv 
MI262 +KpALS  
-Ilv 
MI262 +KpALS  
+Ilv 
C 
KpALS  
–Ilv +Amp 
KpALS  
+Ilv +Amp 
- - 
D 
KpALS  
-Ilv +Amp +0.00002% Ara 
KpALS  
+Ilv +Amp +0.00002% Ara 
KpALS  
-Ilv +0.00002% Ara 
KpALS  
+Ilv  +0.00002% Ara 
E 
KpALS  
-Ilv +Amp +0.0002% Ara 
KpALS  
+Ilv +Amp +0.0002% Ara 
KpALS 
 -Ilv  +0.0002% Ara 
KpALS  
+Ilv  +0.0002% Ara 
F 
KpALS  
-Ilv +Amp +0.002% Ara 
KpALS  
+Ilv +Amp +0.002% Ara 
KpALS  
-Ilv  +0.002% Ara 
KpALS  
+Ilv  +0.002% Ara 
G 
KpALS  
-Ilv +Amp +0.02% Ara 
KpALS  
+Ilv +Amp +0.02% Ara 
KpALS  
-Ilv  +0.02% Ara 
KpALS  
+Ilv  +0.02% Ara 
H 
KpALS  
-Ilv +Amp +0.2% Ara 
KpALS  
+Ilv +Amp +0.2% Ara 
KpALS  
-Ilv  +0.2% Ara 
KpALS  
+Ilv  +0.2% Ara 
 
KpALS – indicates media was inoculated with MI262 cells transformed with pBADKpALS 
+Ilv – indicates media is supplemented with isoleucine and valine 
-Ilv – indicates media without isoleucine and valine 
% Ara – indicates final arabinose concentration in weight percent 
 
 
 
1
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Figure 5.6: Growth curves of MI262 cells in minimal media with and without isoleucine and valine. 
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5.2.4 Growth complementation in media without valine supplementation 
To determine whether KpALS can complement growth under any conditions, experiments 
were performed using media that contained only one of the amino acids, either isoleucine or valine.  
 
 
Figure 5.7: Plate setup and results from growth complementation studies in media without 
valine. Each condition was tested in triplicate. 
Figure 5.7 shows clearly that, when sufficient KpALS is expressed, the enzyme is able to 
complement growth in media lacking valine. Consistent growth complementation was observed at 
arabinose concentrations of 0.002% and higher. However, long lag phases were observed at 
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arabinose concentrations below 0.2%. Unfortunately, no growth was observed in media lacking 
isoleucine (data not shown). 
One problem arising from these experiments was the observation of false positives. A 
prime example of this is the growth seen in one of the wells containing 0.0002% arabinose (Figure 
5.7). This was ruled a false positive as growth was only observed in one out of three replicates. 
False positives were observed in other experiments so care was taken to verify results.  
In a final experiment to determine the viability of the methodology, MI262 cells were 
transformed with an expression vector containing the gene encoding for KpAHAS. The plasmid, 
pBADKpIlvGM, was constructed as described in Section 2.2.3.  The transformed MI262 cells were 
then grown in three minimal media conditions: i) -valine, ii)  -isoleucine, and iii) -isoleucine and 
-valine. As seen in Figure 5.8, excellent growth complementation was observed all media 
conditions when KpAHAS was expressed in the cells.  
In summary, KpALS was able to promote growth only in media that contained 
supplemental isoleucine whereas KpAHAS was able to promote growth in media lacking both 
isoleucine and valine.  
 
 
Figure 5.8: Growth of MI262 cells transformed with vectors containing KpALS and KpAHAS. 
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5.3 Mutagenesis of KpALS to promote growth complementation 
5.3.1 Identification of candidate residues for mutagenesis 
The results from the previous section provide evidence that (i) the growth complementation 
assay is a suitable screen for AHAS activity and (ii) the lack of growth complementation by 
KpALS stems directly from its inability to support isoleucine biosynthesis. Knowing that 
acetohydroxybutyrate is the product of the carboligation of a pyruvate donor and a α-ketobutyrate 
acceptor, and that KpALS can use pyruvate as an acceptor, the question then becomes, “can 
mutagenesis be used to modify KpALS to use α-ketobutyrate as an acceptor?”  
The active site of KpALS was examined for clues as to which residues could have an 
influence on substrate specificity. The structure of KpALS soaked with pyruvate (described in 
Chapter 3), contains ALThDP, the reaction intermediate formed just before product release. This 
is significant as it can provide insight on which residues are in close proximity to the intermediate. 
Focus was placed on the methyl groups, particularly that of the acceptor substrate (orange, Figure 
5.9), as the other atoms in the reaction intermediate (i.e. the oxo and carboxyl moieties) likely 
exhibit a similar conformation during acetohydroxybutyrate formation. During formation of 
acetohydroxybutyrate, this methyl group is replaced by the larger ethyl group. 
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Figure 5.9: Active site residues (green) near the donor and 
acceptor methyl groups of ALThDP (tan and orange, 
respectively). 
  
As seen in Figure 5.9, the active site in KpALS appears too tight to accommodate an ethyl 
group in this position. The three residues surrounding the methyl groups of ALThDP were 
identified as Met394, Gln420, and Met479. These three residues appear to surround both methyl 
groups, and it is clear that a larger acceptor substrate such as α-ketobutyrate would be subject to 
significant steric interference. As such, all three residues were considered as candidates for 
mutagenesis studies in an attempt to open the active site to accommodate α-ketobutyrate. 
Additionally, another residue, Gln483 was considered due to its proposed involvement in 
positioning of the acceptor substrate (46), as discussed in Chapter 3.  
Of the residues identified for mutagenesis, only Met479 is conserved in KpAHAS. Met394 
is replaced by valine, Gln420 by glycine residue and a tryptophan residue is found in a spatially 
similar position to Gln483.  
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5.3.2 Generation and functional testing of active site variants 
The first variants of KpALS to be tested, M394V and Q420A, were generated using site-
directed mutagenesis. These variants were chosen as they would potentially mimic the active site 
of AHAS at each position. For Q420A, alanine was chosen over glycine to ensure that the protein 
backbone structure was affected as little as possible by the change. Sequences of primers used in 
the preparation of the KpALS variants are presented in Table 5.3. All variants were generated 
using the methods described in section 2.6.3 using the pBADKpALS plasmid as a template. 
  
Table 5.3: List of primers used for mutagenesis of pBADKpALS. 
Primer Name Sequence 
  
M394V For 5’-CCGTGGACgTGGGaAGCTTCCATATCTGGATTGCCCGCTACC-3’ 
 
M394V Rev 
 
5’-GGTAGCGGGCAATCCAGATATGGAAGCTtCCCACGtCCACGG-3’ 
 
Q420A For 
 
5’-GTGATGATCTCCAACGGCCAGgcGACcATGGGCGTCGCCCTGCCCTG-3’ 
 
Q420A Rev 
 
5’-CAGGGCAGGGCGACGCCCATgGTCgcCTGGCCGTTGGAGATCATCAC-3’ 
 
Q420 SSM For 
 
5’-CTCCAACGGCCAGnnkACcATGGGCGTCGCCCTGC-3’ 
 
Q420 SSM Rev 
 
5’-GCAGGGCGACGCCCATgGTknnCTGGCCGTTGGAG-3’ 
 
M479A/Q483A For 
 
5’-GGCTACAACgcGGTCGCTATCgcGGAAGAGAAAAAATATCAGaGaCTGTCCGGCGTCGAG-3’ 
 
M479A/Q483A Rev 
 
 
5’-TTCTCTTCCgcGATAGCGACCgcGTTGTAGCCGTTATCGACCCAGATAAGATGCAGCACG-3’ 
 
Bases in lowercase indicate mismatch with the template DNA.  
Primers were designed to include an extra silent mutation to introduce or remove a restriction site for quick screening following PCR 
 
1
4
2
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The first KpALS variant to be tested was M394V. Growth complementation studies were 
performed with cells transformed with this variant in media lacking valine (-Val), isoleucine (-Ile), 
and both valine and isoleucine (-Ilv). The variant was seen to exhibit patterns similar to that of the 
wild-type enzyme in that growth was only observed in media lacking valine, i.e. absence of 
isoleucine in the media resulted in no cell growth. However, one major difference was observed. 
The M394V variant was only able to complement growth in media containing at least 0.2% 
arabinose. This indicated that, while the variant was still active, it is possibly less active than the 
wild-type enzyme. 
The second variant to be tested was Q420A. This variant was tested in all media conditions, 
and again, growth was only observed in media lacking valine. Taken together, testing of the 
M394V and Q420A variants indicate that simply swapping residues to mimic the active site of 
another enzyme does not always give the expected results indicating the necessity of a broader 
approach. Such a lesson has been learned previously in this laboratory while attempting to engineer 
the active site of another ThDP-dependent enzyme, benzoylformate decarboxylase (47).  
One such approach would be to use saturation mutagenesis to simultaneously introduce 
multiple different residues into a given position. This technique has shown positive results in a 
variety of cases from inverting stereospecificity to altering the substrate profile of an enzyme (47-
50). Further, in addition to using saturation mutagenesis, introducing mutations at multiple sites, 
either iteratively or simultaneously, would be more likely provide a KpALS variant able to support 
growth in media without isoleucine.  
Although Met394 and Met479 were also identified as mutagenesis candidates based on 
proximity to the acetolactyl moiety (Figure 5.8), it was noted that Met479 is conserved in AHAS, 
and Met394 is expected to contribute more to the specificity of the donor rather than the acceptor 
substrate (Figure 5.8). Although the possibility cannot be ruled out, mutation of these residues was 
considered less likely to promote use of α-ketobutyrate as an acceptor substrate. Consequently, 
Gln420 was chosen as the first target for saturation mutagenesis as it was predicted to be the largest 
single contributor to the substrate specificity in KpALS. To examine this, degenerate primers were 
designed to introduce mutations at this position. 
Site-saturation mutagenesis was performed as outlined in Section 2.6.3. One of the pitfalls 
of this technique is the screening burden following mutagenesis particularly if a completely 
random (NNN) library is used. As such, the degenerate primers (Table 5.3) were designed using 
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an NNK library. This library permits the screening required to ensure 95% coverage of all the 
possible amino acids at the position of interest to be completed using a single 96-well plate (51).  
Following mutagenesis, it was discovered that MI262 cells showed poor transformation 
efficiency when transformed using the PCR mixture. To alleviate this, the PCR mixture was 
instead transformed into TOP10 cells and plated on agar containing ampicillin. Resulting colonies 
were then collected, mixed and grown in a 3 mL culture, before the plasmid DNA was extracted 
for transformation into MI262 cells. Using this methodology, the transformation proved to be 
much more efficient, providing significantly more colonies that obtained if the PCR mixture was 
directly transformed into MI262 cells. 
The colonies of MI262 cells transformed with site-saturation mutants of Q420X were 
individually picked and tested for growth in (-Val) and (-Ile) media. As with the previously tested 
variants, growth was only observed in media lacking valine. Further mutagenesis was performed 
to create double variants M394V/Q420X and M479A/Q483A, all yielding the same results, i.e., 
no growth was observed in media lacking isoleucine. 
5.4 Summary and Conclusions 
Conferring specific herbicide resistance to plants through expression of an enzyme resistant 
to inhibition by that herbicide has seen great commercial success (22). While this is an attractive 
option to control unwanted growth in crop production, identification of a suitable target enzyme is 
not trivial. The work described in this chapter demonstrates this quite well. Initially, it was shown 
that KpALS was not inhibited by the sulfonylurea herbicide, chlorsulfuron (Figure 5.3), and 
comparison of the sulfonylurea binding site in AHAS, with the homologous site in KpALS 
indicated that important residues were lacking in the latter. Given that X-ray structures have shown 
imidazolinone herbicides to bind in a similar manner (7), it may be expected that KpALS would 
be resistant to both classes of herbicides. Consequently, an appropriately modified KpALS would 
appear to be a strong candidate to confer herbicide resistance to a target plant. 
Using AHAS knockout strains of E. coli it was determined that wild-type KpALS was not 
able support growth in the absence of isoleucine, but was able to compensate for the absence of 
valine. This was not surprising as it has been shown (Chapter 3) that ALS catalyzes the formation 
of the valine precursor, acetolactate, but not acetohydroxybutyrate which is required for the 
biosynthesis of isoleucine. 
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While acetolactate is formed from two molecules of pyruvate, acetohydroxybutyrate is 
formed from one molecule of pyruvate and one molecule of a  marginally larger substrate, α-
ketobutyrate (Figure 1.13). Remarkably, it appears that KpALS is able to effectively discriminate 
between pyruvate and α-ketobutyrate based on the presence of a single methyl group. The residues 
in KpALS most likely to contribute to this specificity were identified as Met394, Gln420, Met479, 
and Gln483. In an attempt to open the active site to accommodate the larger substrate these residues 
were subjected to site-directed mutagenesis, and, in the case of Gln420, site-saturation 
mutagenesis. Unfortunately, none of these attempts produced a KpALS variant able to support 
growth in isoleucine deficient minimal media. 
With the benefit of hindsight, and some experiments described in Chapter 3, it is perhaps 
not surprising the growth complementation experiments were not successful. But that does not 
necessarily mean the mutagenesis was not a success as it should be recognized that inability to 
support cell growth does not necessarily indicate a total inability to use α-ketobutyrate as an 
acceptor substrate. Over 30 years ago it was established that cellular levels of α-ketobutyrate are 
nearly 100-fold lower than those of pyruvate (52,53). This presents a sizeable challenge; KpALS 
likely cannot be engineered to simply utilize α-ketobutyrate, it must to be engineered to have a 
strong preference for it as the acceptor substrate. If this does not happen, in vivo pyruvate will out-
compete α-ketobutyrate.  
As shown in Chapter 3, wild-type KpALS shows a ~10-fold preference for pyruvate as an 
acceptor substrate. When that is considered in conjunction with the cellular levels of pyruvate and 
α-ketobutyrate, a rough calculation suggests that, in vivo, KpALS will likely form ~1000-fold more 
acetolactate than acetohydroxybutyrate. On the other hand, KpAHAS showed a ~70-fold 
preference for α-ketobutyrate so, under the same conditions KpAHAS will form acetolactate and 
acetohydroxybutyrate in roughly equal amounts.  
Continuing in that vein, to engineer KpALS so as to catalyze the formation of these 
products in a ratio equivalent to that catalyzed by KpAHAS, a ~700-fold increase in preference for 
α-ketobutyrate will be required. To make things more difficult, KpALS has a Km value for pyruvate 
at least 2-fold higher than that of KpAHAS, making the latter better equipped to cope with low 
intracellular levels. While it is not impossible that KpALS could ultimately achieve the specificity 
required, there certainly can be no guarantee that it will. Given the magnitude of the task, it may 
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prove easier to develop an herbicide-resistant AHAS rather than engineering the active site of 
KpALS. 
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